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Abstract
The successful poultry production at modern era comes from the vertical integrated
industrialization, which has fundamentally changed how animals have been living for millions of
years. Antimicrobial growth promoters have been used to sustain the efficient industrialized animal
production, driving antimicrobial overuse and resistance. Because of the increasing pressure from
consumer’s concerns and government regulations, it is urgent to develop antimicrobial free
alternatives as growth promoters in poultry production, but few effective antimicrobial alternatives
are currently available. Campylobacter jejuni is one of the worldwide prevalent foodborne
bacterial pathogens mainly transmitted from poultry. However, few mechanisms are available on
why C. jejuni colonizes chickens. In the first chapter, I have presented an overview of current
knowledge on microbiota, chicken growth and C. jejuni infection.
In the second chapter, we aimed to investigate the mechanism of transplanting microbiota
on C. jejuni chicken colonization. Mouse specific pathogen free (SPF) microbiota was cultured on
Brain Heart Infusion agar (BHI) and collected as SPF-Aerobe and SPF-Anaerobe. Birds raised on
floor pens were colonized with 108 CFU/bird SPF-Aerobe and SPF-Anaerobe at d 0 and infected
with 109 CFU/bird C. jejuni chicken isolate AR101 at d 12. Birds were sacrificed at d 21 and 28 to
enumerate C. jejuni cecal colonization on selective Campylobacter plates. The results show both
SPF- Aerobe and SPF-Anaerobe microbiota reduced C. jejuni chicken colonization compare to
infected birds at d 21 and 28, Also, we found that SPF-mouse microbiota was able to colonize in
chicken gut by modulating chicken microbiota at phylum level. Furthermore, SPF-mouse
microbiota prevented C. jejuni growth in vitro.
In the third chapter, we investigated investigate the effect of transplanting microbiota on
the bird growth performance. Mouse SPF stool was cultured on Brain Heart Infusion (BHI) agar

under anaerobic or aerobic condition and collected as SPF-Aerobe and SPF-Anaerobe microbiota.
Day-old birds were tagged, weighed, and randomly assigned to 8 pens with 15 birds/pen. The birds
were orally gavaged with PBS (3 pens), 108 CFU/bird SPF-Aerobe (2 pens) or SPF-Anaerobe (3
pens). The feed intake and individual bird weight were measured at d 0, 14, 21 and 28. The broiler
chickens were euthanized at d 14, 21 and 28. Intestinal digesta was collected to measure nutrient
and bacteria levels. Notably, SPF-Aerobe and SPF-Anaerobe significantly increased body weight
gain by 18% and 12% during d 0 to d 14, respectively, compared to the negative control. No
significant difference of feed intake was observed among the groups. SPF-Aerobe significantly
reduced periodic feed conversion ratio compared to the negative control by 20% during d 21 to 28.
Both SPF-Aerobe and SPF-Anaerobe microbiota reduced accumulative feed conversion ratio
compared to negative control by 18% and 14% respectively, during d 0-28. SPF microbiota
increased the levels of macro-nutrients of gross energy, protein and fat in the digesta of the small
intestine compared to the negative control. SPF-Anaerobe transplantation increased phylum
Bacteroidetes but reduced Firmicutes in the digesta of small intestine and ceca compared to the
negative control.
In conclusion, microbiota was able to reduce C. jejuni chicken colonization and to improve
feed efficiency and early bird body weight gain. The results suggest that microbiota reconstitution
in chickens could be used an effective antibiotic alternative to reduce foodborne pathogen C. jejuni
and to improve poultry productivity.
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CHAPTER I
Literature Review
1.1

Introduction
Animal meat is an important component of human diet that provides a range of micro and

macro nutrients like fats, vitamins, minerals, and proteins. Meat is generally rich in proteins and
so, can fulfill most of the human body’s protein requirements (Ahmad et al., 2018). Meat
consumption is expected to increase by 14% in the next decade. The poultry industry, which plays
a critical role in food security and nutrition around the world, is among the fastest-growing
subsectors in agriculture, particularly in developing nations. According to the Food and
Agriculture Organization (FAO) of the United Nations, the estimated poultry meat produced in
2020 was around 333.7 million (FAO, 2020). Poultry is also expected to be a predominant source
of meat and proteins in the future, accounting for 41% of the total meat consumption in the year
2030 (OECD-FAO, 2021). Chickens, along with turkeys, are the most widely bred and consumed
poultry species on earth, accounting for roughly 36% of the total protein consumption (FAO, 2014;
OECD-FAO, 2021). Currently, the major chicken meat producing countries are the United States
and Brazil (USDA, 2020). The chicken meat sector is expected to grow further in future mainly
due to the factors like population and income level growth and increasing urbanization. (FAO,
2020). For meat to be considered acceptable for consumption, it must meet some quality
parameters. Factors that affect meat quality include its physical, biochemical, sensory, and
microbial properties (Rodríguez-Carpena et al., 2011). The microbial content of meat is of
paramount importance for food safety as presence of pathogenic bacteria can cause foodborne
illnesses, thus, meat can function as a vector for spread of zoonotic diseases. Bacterial species such
as Salmonella, Campylobacters, Listeria Monocytogenes, Escherichia coli (E. coli), and
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Clostridium are major foodborne pathogens and thus, their presence in meat is a cause of great
concern regarding safe consumption of such meat (Dhama et al., 2013). The chicken meat often
serves as a vector of zoonotic diseases to humans including campylobacteriosis, a foodborne
infection caused by bacterium Campylobacter jejuni (C. jejuni) that infects around 33 million
people each year (Havelaar et al., 2015; WHO, 2020).
C. jejuni is a prominent and significant zoonotic pathogen that acts as a source of severe
and frequent intestinal infections among humans. The situation is most critical in the industrialized
nations, where C. jejuni is recognized as the most prevalent causative agent of foodborne illnesses
(Sheppard et al., 2012). The utmost reported origin of human Campylobacter infections are the
farm animals, where the pathogen is most widely spread. These animals carry the pathogen without
any visible signs. More specifically, poultry is the primary cause of human C.
jejuni intestinal infections

that

account

for

approximately

80%

of

all

campylobacteriosis infections worldwide (Hazards, 2010). This bacterial specie is believed to
normally inhabit the intestinal mucosa of chicken, which spreads to humans by eating
contaminated chicken meat (Hermans et al., 2011). C. jejuni infections are typically selflimiting that barely last for a few days. So, in most cases, antibiotic treatment is usually not
required. Macrolides, like erythromycin, are currently widely regarded as the best treatment
option for the C. jejuni infections, while fluoroquinolones serve as an alternative. Nevertheless,
antimicrobial resistance in Campylobacter strains is becoming a widely recognized problem that
is a major concern for infection treatment (Guyard-Nicodème et al., 2015). The rising incidence
of antibiotic resistant C. jejuni infections in human renders clinical therapy of the diseases caused
by this bacterium more challenging. Antibiotic resistance can lengthen sickness and complicate
the treatment of bacteremia patients (Snelling et al., 2005).
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C. jejuni naturally infects poultry by the fecal–oral pathway. This is followed by the
establishment of this bacterium in the birds' intestinal tract with a significant bacterial presence in
the caeca (approximately 109 colony-forming units (CFU)/g of cecal contents) (Sahin et al., 2015).
Once C. jejuni infects and establishes itself in a single chicken, it can quickly spread to
the whole flock, and within a matter of few days, the entire flock can be infected. The ceca and
small intestines act as the primary areas of colonization, with the deep muscles, fabricius bursa,
liver, spleen, and thymus also acting as the infection sites to a lesser extent. Despite high infection
rates and speed of colonization, C. jejuni mainly remains apathogenic in chicken (Awad et al.,
2015; Chaloner et al., 2014; Cox et al., 2005; Humphrey et al., 2015). However, this notion has
been challenged by many studies that sprung up during the last few years reporting detrimental
effects of C. jejuni that include impairment of the chicken’s intestinal mucosa, increased intestinal
permeability and reduced food absorption in the intestines (Awad et al., 2016; Awad et al., 2018).
Antibiotics have been traditionally used at sub-therapeutic and therapeutic levels to promote
growth and welfare of chicken. However, due to the rising antimicrobial resistance, the use of
antibiotics in livestock production is receiving increased scrutiny and discouragement (Elhadidy
et al., 2018)
Due to the ever-increasing cases of campylobacteriosis around the world including the
United States, investigations into the use of therapeutics alternatives to antibiotics are urgently
needed as the treatment failures using antibiotics continue to increase globally. Implementation of
the biosecurity measures in poultry farms, vaccinations , treatment with phages, probiotics, and
poultry carcass disinfection are among the most studied alternative intervention strategies
(Alrubaye et al., 2019). Although these measures decrease C. jejuni bacterial counts, more
effective alternative approaches are urgently required, as evidenced by the consistently high
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overall campylobacteriosis incidences reported around the world (WHO, 2020). There is currently
little information available on utilizing microbiota to inhibit C. jejuni colonization in poultry.
Microbiota transplantation has been proven to be highly effective in treating recurring Clostridium
difficile infections in humans (Buffie et al., 2015; Silverman et al., 2010). Recent findings suggest
that some anaerobic bacteria protect Il10-/- mice from the intestinal inflammation caused by C.
jejuni. Moreover, it has been found that wild type mice containing intact conventional microbiota
are protected from colonization by C. jejuni, even after high peroral infection dosage of C. jejuni
(Heimesaat et al., 2019b; Sun, Jia, et al., 2018). While fecal microbiota transplantation (FMT) is
becoming more widely used in human therapeutic practice, it is yet to be embraced in livestock in
the true sense (Heimesaat et al., 2019b).
1.2

C. jejuni
C. jejuni belongs to the genus Campylobacter which contains over 28 other species besides

C. jejuni. A wide variety of animals like poultry, cattle, and sheep naturally carry C. jejuni in their
intestine. Chickens are the primary reservoir of this bacterium though it is mostly found in older
chickens and rarely in chickens younger than 2 weeks. It has been postulated that the maternal
antibodies in young chicks are mainly responsible for conferring protection against C. jejuni
colonization. In majority of cases, C. jejuni does not cause infection in chickens and resides in the
chicken gastrointestinal tract (Nauta et al., 2009) as a commensal bacterium (Awad et al., 2018).
However, the bacterial specie is pathogenic to humans as it is responsible for the 95% of all
campylobacteriosis cases, a foodborne disease that causes enteritis (CDC, 2021). According to
direct and indirect data from experimental infections and aquatic outbreaks, respectively, exposure
to mere hundreds of C. jejuni cells is enough to cause disease. The primary route C. jejuni
dissemination into human population is chicken meat. However, chicken and human fecal
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contamination of food and water sources are also recognized as significant sources of C. jejuni
transmission (Pitkänen & Hänninen, 2017).
1.2.1

History of C. jejuni
Campylobacters were discovered by Theodor Escherich, who in 1886, identified the

presence of spiral-shaped bacteria in the neonates' diarrheic stool samples. He named the range of
symptoms caused by these newly discovered bacteria in children as “cholera infantum” and
summer complaint (Condran & Murphy, 2008; Escherich, 1886; Samie et al., 2007). Several
morphologically same spiral or "Vibrio" bacteria were later isolated by McFadyean and Stockman
from different animals in 1906. They also isolated a bacterial specie which they named Vibrio
foetus ovid based on their isolation from aborted lamb fetuses and their mothers (McFadyean &
Stockman, 1909). The bacterium was then renamed to Campylobacter fetus in 1963 (Sebald &
Veron, 1963). Véron and Chatelain (1973) proposed a new genus called Campylobacter to include
all these bacteria including the bacterium now called C. jejuni (Acheson & Allos, 2001). This
classification was made after clinical microbiologists in Belgium successfully isolated these
bacteria from the stools of diarrheal patients in 1972, following King's 1957 report on the isolation
of "Vibrio" bacteria samples from the blood of children having diarrhea. Soon after this report,
Campylobacter became increasingly recognized as a common human pathogen. This realization
was made after several laboratories started routine isolation and identification of Campylobacter
from the stool sample due to the advancements in selective growth media in the early 1970s (Kist,
1985; Tauxe, 1992). By the mid-1980s, various scientific publications established Campylobacter
as one of the leading causes of diarrhea around the globe (Acheson & Allos, 2001).
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1.2.2

Morphology and biochemical characteristic
C. jejuni are gram-negative curved rods, motile, and non-spore forming morphologically,

and signifies its presence with highly motility due to presence of polar flagellum at one or both
ends of the cell. Size varies from 0.2 to 0.8 µm wide and 0.5 to 5.0 µm long. The daughter cells
are often attached together showing spiral forms. The bacterium has a preference for poultry such
as chicken as the body temperature of these birds is ideal for its growth as evidenced by its ability
to grow best at 42oC. However, temperature between 30 and 44oC can also support the growth of
this bacterium (Nielsen et al., 2010). C. jejuni is microaerophilic and requires an oxygen
concentration in range from 3 to 15% and 3 to 5% carbon dioxide. Biochemically, these bacteria
are catalase and oxidase positive and urease negative, and can hydrolyse hippurate (Hansson,
2007). Campylobacter species can have unipolar or bipolar flagella that allow motility in the
bacterial species. C. jejuni grows slowly; initial isolation of these bacteria from stool samples
takes 72–96 hours, while isolation from blood samples requires even more time (Murray et al.,
2008). The bacterium requires a balanced amount of nitrogen, 3-15% oxygen concentration, and
carbon concentration of 3-5% (Murray et al., 2008; Nielsen, 2010). C. jejuni cannot ferment
carbohydrates, so they take energy by reducing carboxylic acids and amino acid substrates. It can
reduce nitrate and fumarate to succinate. The bacterium is biochemically oxidase and catalasepositive, while its urease-negative has the property to establish a long-term association with its
host (Vandamme et al., 1992).
C. jejuni is a slow growing and fastidious microorganism that requires specific set of
laboratory conditions for its isolation. In the food samples, presence of other bacteria that are fast
growing limits isolation of C. jejuni. Therefore, enrichment of food samples is required to allow
small number of C. jejuni cells to proliferate and be used for the isolation of this bacterium.
Normally, peptone water is used for this purpose (Gharst et al., 2013). The sample containing
6

enriched bacterial colonies is then plated on selective media for the isolation. The selective
medium can be blood-based such as the media developed by Bolton and Robertson (1982) or a
blood-free medium which contains charcoal, cefoperazone, and deoxycholate and is called CCD
agar based on the initials of these three components (Bolton et al., 1984). Once plated, the bacterial
plates are incubated at microaerophilic conditions and at higher temperatures preferably 42oC
(Gharst et al., 2013).
1.2.3

C. jejuni chicken colonization
The rate of Campylobacter spread in poultry is much higher than in any other animal. It

has been shown that after colonizing the gastrointestinal tract (Nauta et al., 2009) of one bird, rapid
transmission occurs horizontally, after which, the whole flock can acquire C. jejuni infection
within few days (Horrocks et al., 2009; Shreeve et al., 2000). Because of such high spread in
chickens, C. jejuni can be found ubiquitous in the environment surrounding chickens (Newell et
al., 2003). Infection originates primarily in the ceca and small intestine, with secondary infections
occurring in the deep muscles, fabricius bursa, liver, spleen, and thymus. Despite high infection
rates and speed of colonization, chickens remain asymptomatic in overwhelmingly majority of
cases (Awad et al., 2018). Though C. jejuni and similar species are nearly ubiquitous inhabitants
of avian digestive tracts, numerous studies suggest that they have poor survivability outside of
these environments. It has also been widely observed that C. jejuni metabolic capacities are limited
in comparison to other digestive tract microbial occupants like Bacteroidetes and E. coli, so C.
jejuni and similar species have been labelled as metabolically fastidious (Murphy et al., 2006).
This lifestyle indicates that C. jejuni cannot withstand changes in the pH and oxygen levels,
osmotic, temperature conditions, and limited nutritional availability. C. jejuni is a thermophilic
bacterium belonging to Campylobacter species that grows best between 37°C and 42°C, and does
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not replicate below 30°C (Penner, 1988) . It was proposed that the pathogen's failure to proliferate
at the reduced temperatures could be attributed to a lack of cold-shock proteins (Hazeleger et al.,
1998). However, C. jejuni can respire and generate ATP even in lower temperatures like 4°C,
allowing it to perform its metabolic activity for longer time periods at low temperatures. Because
of this reason, refrigerated chicken meat contaminated with C. jejuni can also serve as the cause
of infections as the bacterium can grow at refrigeration temperatures (Bhaduri & Cottrell, 2004).
Initially thought of as a commensal bacterium in chicken, it was later discovered that C.
jejuni is capable of invading the intestinal mucosa of chicken and spreading to internal organs
(Lamb-Rosteski et al., 2008; Van Deun et al., 2008). Moreover, C. jejuni colonization in the
chicken gut has been found to be associated with mucosal injury and increased intestinal
permeability, implying that C. jejuni translocate through the transcellular and paracellular
pathways. C. jejuni also alters host cellular activities by interacting with the intestinal epithelium
and by disrupting Ca2+ signaling and nutritional absorption in chickens (Awad et al., 2016). The
physiology and metabolic profile of C. jejuni infection in chickens is less known in comparison
with other food-borne infections (Howlett et al., 2014). C. jejuni has a high requirement for noncarbohydrate derived carbon sources due to its low capacity to metabolize sugars and lack of
phosphofructokinase enzymes (Parkhill et al., 2000). Previous research has indicated that the
bacterium uses only a small number of TCA cycle intermediates and amino acids as essential
carbon sources. The bacterial ability to utilize aspartate, glutamate, proline and serine is a
characteristic of C. jejuni infections (Howlett et al., 2014). Investigations regarding the metabolic
capabilities of C. jejuni and how these relate to the colonization of host species and virulence are
just beginning to emerge to expand insight and offer possibilities for C. jejuni infection control.
As a result, better knowledge of the pathogen’s metabolism and the impact of diverse substrates
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on its physiology is critical in defining adaptability and colonization of this bacterium in different
host niches, as well as pathogenicity (van der Hooft et al., 2018).
1.2.4

Virulence factors of C. jejuni in chickens
To successfully colonize in the GIT of chicken, C. jejuni has to make use of various

physiological processes requiring many factors. Over the last three decades, a great insight about
the several strategies that C. jejuni uses for colonizing chickens has been gained. The majority of
genes that are important for colonization of C. jejuni are encoded in the plasmids like pVir plasmid,
which makes it easy for these genes to spread among the bacterial populations (Hassan et al.,
2019). To survive for an extended period of time, C. jejuni has acquired tolerance for the acidic
pH and alkaline bile during transition through gut and cecal colonization (Beery et al., 1988). The
movement of bacteria move through hostile organs to relatively safer environments is facilitated
by the bacterial ability to move with the help of flagella and through chemotaxis (Hermans et al.,
2011). Various studies have highlighted the crucial role of motility in successful and longterm colonization of chickens by C. jejuni. Motile C. jejuni colonize the chicken ceca for extended
periods of time with much greater efficiency and larger numbers than non-motile mutants (Mertins
et al., 2012; Morooka et al., 1985). When C. jejuni enters the target organs, it attaches itself to
epithelial cells before colonizing them (Beery et al., 1988). The colonization of host is aided by a
well-functional Quorum Sensing (QS) system present in C. jejuni just like in other bacteria. QS
helps in different bacterial processes, including biofilm formation, CDT transcription (Jeon et al.,
2003), autoagglutination, motility packing, colonization of animals, and in expression of many
other virulence factors (Quiñones et al., 2009). C. jejuni uses QS to identify changes in host
environment and microbial populations by creating signaling molecules such as autoinducer-2, or
AI-2 (Bassler et al., 1994; Castillo et al., 2014). The AI-2 gene which is induced by methylene
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recycling pathway (Plummer, 2012) is primarily involved in motility, flagella expression,
oxidative stress, and bacterial colony formation. Information about the environment and other C.
jejuni cells obtained through QS is important for the formation of C. jejuni colonies in the host.
Once the host is successfully colonized, C. jejuni can then form biofilms which help it to withstand
any stress imposed by the host and the new environment. The biofilm is a defensive structure that
provides a protective sheath to the bacteria under which they can reside in a relatively dormant
state until favorable conditions return (Chmielewski & Frank, 2003; Murphy et al., 2006).
1.2.5

Persistence of C. jejuni in chickens
The body conditions of chickens are favorable for C. jejuni as high temperature, nutrient

availability, and microaerophilic conditions in the chicken gut make it easy for the C. jejuni cells
to persist in the chicken GIT (Burnham & Hendrixson, 2018). The colonization of chicken gut is
still hostile for the C. jejuni. However, the tolerance to various stressors like pH and varying
nutritional and oxygen concentration conditions aid in overcoming these impediments (Murphy et
al., 2006). The whole list of genetic and regulatory processes used by C. jejuni for permanent and
successful colonization and persistence in the chicken GIT are unknown (Awad et al.,
2018). Chickens rarely show symptoms of disease from colonization by C. jejuni.

Except in

chickens that lack properly developed immune system, and absence of a strong immune response
to the C. jejuni invasion reflects a long-term evolutionary adaptation of this bacterium in the
chicken GIT (Awad et al., 2015; Burnham & Hendrixson, 2018). However, the absence of an early
immune response against C. jejuni by chicken has been shown to allow the bacterium to spread
into other organs like the liver. So, it is surmised that the chicken immune response effectively
keeps C. jejuni population in check and resists colonization of the bacterium in other organs
besides GIT (Vaezirad et al., 2017).
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1.2.6

Antibiotics usage and antibiotic resistance of C. jejuni
Antibiotics are commonly used in poultry farming throughout the globe to enhance

productivity and chicken health. Though, the beneficial effects of antibiotics in chicken growth
and productivity are well established, their effect on altering the chicken microbiota ecology is
also gaining traction. Antibiotic administration harms beneficial populations and promotes growth
of harmful gut bacteria (She et al., 2018). It has been experimentally shown that chickens and mice
treated with antibiotics are highly susceptible to C. jejuni colonization (Giallourou et al., 2018;
Han et al., 2017). Recently, Han et al. (2020) has empirically confirmed that long-term antibiotic
exposure in broiler chickens leads to reduction in diversity of intestinal microbiota, which makes
it easier for C. jejuni to colonize the chicken intestine. This colonization in reduced gut microbial
diversity environment results in development of disease symptoms like diarrhea, intestinal damage
and infiltration of heterophil into the intestine.
The effects of extended exposure of antibiotics are not limited to chicken health only.
Numerous scientific studies over the years have shown that antibiotic resistance in the farm animal
bacteria can spill over to environment and humans through contact and consumption of animal
products (Lu et al., 2021). The injudicious and overuse of antimicrobials select for antibiotic
resistance (ABR) genes in bacteria which are shown to be transferred to humans and the
environment (Marshall & Levy, 2011). The evidence for the selection of ABR genes in bacteria
and their spread to humans was established long time ago. For example, by using chickens fed
with a diet containing tetracycline, a study in 1976 revealed that almost all of the chicken's
intestinal flora contained tetracycline-resistant microbes within a week of eating the diet which
spread to the 31% of all the farm personnel six months after initiating the experiment (Levy et al.,
1976). The spread of ABR costs the economy substantial amounts each year because less effective
antibiotics lead to higher medical costs (Salim et al., 2018). According to an estimate from the
11

European Union (EU), over 25,000 individuals die each year from diseases caused by drugresistant bacteria, costing the healthcare system €1.5 billion. Furthermore, around 90% of
antibiotics given to cattle are excreted into the environment, potentially causing contamination
(Cogliani et al., 2011). These public health safety concerns have led many countries to ban or
restrict the use of antibiotics in the animal feed. The World Health Organization (WHO) has
recommended that the usage of AGPs which are also utilized frequently in human medicine, be
completely stopped until risk studies are completed (WHO, 2012). According to the European
Food Safety Authority (EFSA) report on antimicrobial resistance (Djenane et al.) among zoonotic
and human indicator bacteria, high level of resistance against medically important antibiotics like
ciprofloxacin and tetracycline is an immediate public health concern (EFSA, 2020).
In general, the regions where overuse of antibiotics is common, higher prevalence of
antibiotic resistant C. jejuni strains is expected than the regions with low antibiotic usage in animal
farming (Norström et al., 2007). Studies have reported that regular and injudicious use of
fluoroquinolones (one of the most common antibiotics used in chicken farming) increased
resistance in chicken and human C. jejuni isolates (Wieczorek & Osek, 2013). This not only
increases transmission of C. jejuni into human population from farm animals particularly chicken
but also results in increase in treatment failures of C. jejuni infections. So, the strategies alternative
to antibiotics to decrease C. jejuni prevalence in chickens are urgently needed. It has been
estimated that decreasing C. jejuni bacterial cell levels by 2log10 could result in reduction of 90%
campylobacteriosis cases (EFSA, 2020).
1.2.7

Transmission of C. jejuni
An overwhelming source of C. jejuni transmission in humans is chickens. Other animals

such as cattle and pigs also contribute to a miniscule percentage of C. jejuni infections.
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Transmission of C. jejuni from chickens to humans occurs primarily through consumption of
chicken meat, cross-contamination of contaminated chicken meat in meat processing plants and of
other food and water resources (Es-Soucratti et al., 2020). Chickens act as principle reservoir of
C. jejuni because this bacterium is highly adapted to this animal. It has been experimentally shown
that C. jejuni infection of only one bird is enough to make the whole chicken flock infected with
C. jejuni (Horrocks et al., 2009). In the farm, C. jejuni primarily spreads through chicken feces
when it contaminates water, feed, air, soil and litter. The bacterium gets access to each and every
bird in the flock because all the birds share these resources. Aside from these sources, C. jejuni
can also spread to chickens and to humans through farm workers, flies, rodents, and other animals
that may be present in the farm (Ahmed et al., 2013; Newell et al., 2003). The factors that determine
the spread of C. jejuni transmission among chickens include flock size, working activities,
environmental water supplies, insects, staff, rodents, and population of other birds on the same
farm are major contributors deciding the rate of transmission (Adkin et al., 2006; Horrocks et al.,
2009). Moreover, warmer climates with low oxygen tension levels can also aid in C. jejuni
transmission (Louis et al., 2005).
1.2.8

Campylobacterosis
Campylobacterosis is defined as an infection of the intestines that is caused by bacteria

belonging to the genus Campylobacter particularly by C. jejuni. The infection in the
gastrointestinal tract in some exceptional circumstances could also reach the bloodstream.
Campylobacterosis is typically diagnosed as a moderate, self-limiting gastroenteritis that could be
associated with 1–3 days of headaches, fever, and vomiting followed by abdominal pain
with watery or in extreme cases, bloody diarrhea, lasting 3–7 days (Bolton, 2015). The antibody
targeting C. jejuni surface lipooligosaccharides can auto-immune react with gangliosides in
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the human nervous system, causing serious neurological disorders like Guillain-Barre and Miller
Fisher syndrome (Man, 2011). For C. jejuni to infect and subsequently cause Campylobacterosis,
CFU as low as 360 are sufficient (Hara-Kudo & Takatori, 2011). Studies have revealed that other
bacterial pathogens are also directly linked to Campylobacterosis. In developing countries, E. coli,
rotavirus, and other pathogenic infections were founded to make a person susceptible to
Campylobacterosis, but no such evidence was reported in developed countries (Coker et al., 2002).
Campylobacterosis is one of the most common foodborne and gastrointestinal diseases
around the world. It is usually perceived as a disease of the industrialized nations. In the United
states, more people are affected by Campylobacterosis than any other gastrointestinal disease
totaling around 1.5 million people each year (CDC, 2021; Hoffmann et al., 2021). In the European
Union (EU), Campylobacterosis is also the most prevalent foodborne disease. Around 0.24 million
people in the EU reportedly contracted Campylobacterosis in the year 2018 (EFSA, 2020). Aside
from industrialized countries in the Americas and Western Europe, Campylobacterosis is
also becoming more widespread in Africa, the Middle East, and Asia, especially among
youngsters (Johnson et al., 2017). However, estimations of the burden of Campylobacterosis in
developing countries is much harder due to the lack of surveillance programs and resources for
executing them (Mughal, 2018). Some reports exist on the association between sex, age and living
conditions and susceptibility to Campylobacterosis. A demographic study by Samuel et al. (2004)
indicated that the C. jejuni infection rate is higher in males than in females of all ages. Green et al.
(2006) collected data from Manitoba province, Canada and reported a high rate of
Campylobacterosis in the 0-4 and 20-39 years’ ages group in rural and urban areas of Manitoba,
respectively, with the rate being higher in males. The difference was starker in the 0-4 year age
group in which rural population showed seven times higher Campylobacterosis cases than urban
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population for the same age group. The authors hypothesized that children living in rural
conditions particularly near farms are more susceptible to C. jejuni infection than children living
in cities. In Hesse, Germany, the rate was also found to be higher in individuals under five years
and 5-14 years of age (Fitzenberger et al., 2010). In this study as well, living in rural areas was
associated with significantly higher Campylobacterosis cases.
Human-to-human transmission of Campylobacterosis is sporadic. Usually, Campylobacter
infections are resolved without any antibiotic therapy. In mild diarrheal symptoms, treatment
supporting electrolyte and hydration balance is sufficient (Acheson & Allos, 2001). However,
antibiotic therapy by macrolide antibiotic (erythromycin) and fluoroquinolones (ciprofloxacin) is
needed in certain diarrheal cases (Balfour & Faulds, 1993). If the affected person is pregnant or
already suffering from HIV, antibiotic therapy is also necessary (Acheson & Allos, 2001).
Tetracyclines, Gentamicin (Shen et al., 2018), and Macrolides drugs are also effectively
against Campylobacter infection but only for a limited period (Koningstein et al., 2011).
Antimicrobial resistant, mainly fluoroquinolone-resistant, Campylobacter strains are
causing more infections in humans and animals in developing world where people use antibiotics
more frequently than required. It has complicated the clinical treatment of multi-drug-resistant
(MDR) Campylobacter bacteria (Fields & Swerdlow, 1999; Whelan et al., 2019). Moreover,
resistant C. jejuni are more likely to cause serious campylobacterosis complications than nonresistant strains. This is evidenced by studies showing that extreme outcomes of campylobacterosis
like Guillain-Barre Syndrome (GBS), intestinal hemorrhage, and toxic mega-colon are more
common in people who are infected with the resistant C. jejuni strains (Chamovitz et al., 1983). A
report presented by the Centers for Disease Control and Prevention (CDC) listed the drug-resistant
Campylobacter strains as microorganisms that could pose serious level of threat to public health
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care. The CDC also indicated that about 24% of Campylobacter strains are resistant to
ciprofloxacin (fluoroquinolone) and macrolides. Furthermore, the report indicates that more than
300,000 Campylobacter infections are caused by antibiotic-resistant strains every year in United
States (CDC, 2019; Shen et al., 2018).
1.2.9

Prevention of C. jejuni colonization
The colonization of C. jejuni in chickens can occur through various routes. Reducing the

spread of this bacterium in chickens requires implementation of prevention and control measures
(Nauta et al., 2009). Prevention and control are two different terms. The preventive measures
involve the reduction of chances of C. jejuni infection in chickens. Control measures involve
additional steps and strategies to minimize bacterial presence in poultry before slaughtering the
chickens (Hermans et al., 2011). Efforts to reduce Campylobacter species colonization in chickens
are more fruitful than the controlling environmental exposure due to the more difficulty faced in
the latter case as these bacteria spread faster in the environment (Lin, 2009). The strategies include
reducing C. jejuni colonization in chickens by increasing the resistance of chickens against C.
jejuni infection and use of effective strategies alternative to use of antimicrobials. There have been
many approaches used for this purpose in the past. These include vaccination (Hodgins et al.,
2015), bacteriophage therapy (Kittler et al., 2014), probiotics and prebiotic usage (Arsi et al., 2015;
Gálvez et al., 2007). However, after continuous efforts in this regard, no such efficient method has
been reported to confer a complete barrier against C. jejuni infection in chickens. These measures
have indeed shown some success in controlling C. jejuni spread in chicken flocks. However, they
are ineffective against preventing and controlling complete C. jejuni spread. Due to the high
compatibility of bacteria, it can multiply in nearly all conditions and develop resistance against
these practical measures (Lin, 2009; Vandeputte et al., 2019). Emerging evidence suggests that
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reconstituting the gut microbiota in chicken can confer resistance against C. jejuni colonization in
chicken (Deng et al., 2020; Fu et al., 2021; Han et al., 2017). In the following section, we will
discuss the role of microbiota in maintaining health of chicken as well as prevention of C. jejuni
colonization and then we will discuss microbial modulation of chicken gut as a strategy to control
C. jejuni colonization and transmission in chicken flocks.
1.3

Microbiota
The ecological communities of commensal as well as symbiotic and pathogenic

microorganisms that can colonize the GIT and other parts of the animal body are called microbiota
(Sender et al., 2016). Gut microbiota are the organisms that live in the digestive tract of living
organisms and often provide beneficial effects to host body functioning. The microbes present in
the gut region and their metabolites are collectively called microbiome (Sun, Jia, et al., 2018). It
has been reported that the bacterial cells outnumber the host cells by nearly ten to one (Hooper &
Gordon, 2001). Chicken at the first day of life shows microbiota presence in their gut, indicating
that it acquires it at their embryonic stage either from the mother parent directly (Gantois et al.,
2009) or through the pores of eggshells from the environment (Roto et al., 2016), which also
constitute as an important source of microbiota transfer to chicken at the hatchery (Pedroso et al.,
2005). Kizerwetter-Świda et al. (2008) reported the presence of microbiota in 18 and 20-day old
embryos by showing their presence in the liver, yolk, and Ceca. Chicken microbiota is different
from that of humans. Wei et al. (2013) reported the presence of 915 operational taxonomic units
(OTUs) as broiler microflora. Among them, 13 phyla count for 90% of total microbiota, with
Firmicutes (70%), Bacteroidetes (12.3%), and Proteobacteria (9.3%) being the highest in the
count. The other phyla observed were Actinobacteria, Cyanobacteria, Spirochaetes, Synergisteles,
Fusobacteria, Tenericutes, and Verrucomicrobia (Wei et al., 2013). A more recent study reported
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a total of 117 genera, with Ethanoligenes, Clostridium, Ruminococcus, Lactobacillus,
Desulfohalobium, and Bifidobacterium constituting the majority (Ballou et al., 2016). The
microbial diversity is not same throughout the body and varies depending on the particular
environment of the organ and also the age of the chickens (Deng et al., 2020; Hooper & Gordon,
2001), with majority of the microbiota residing in the GIT of animals (Guarner & Malagelada,
2003). Even within the GIT, variation in microbiota still exists. The cecum and ileum contain an
abundance of Gram positive bacteria and are dominated by bacteria such as Bacillus, Clostridia,
Lactobacillus, and Streptococci (Lu et al., 2003). However, differences in microbial taxonomic
diversity exists between these organs (Awad et al., 2016; Feye et al., 2020). This difference
becomes starker as the chicken mature. For example, the cecum in chickens is dominated by
Clostridiacae while Lactobacilli are predominant in the ileum (Lu et al., 2003). Overall, the gut
microbiota plays a crucial role in metabolism of nutrients as well as the formation of healthy
immune response and present barrier against colonization by the foreign pathogens. So, gut
microbial homeostasis is essential for all animals as it plays a vital role for the host’s digestive,
metabolic, and immune systems (Ballou et al., 2016).
The microbial antigens compartmentalized in the host by mucous epithelial cells layer
stimulate the intestinal immune system regularly. The biochemical signals generated by microbiota
play an essential role in maintaining the complex interaction of microbe-host symbiotic relations.
The pattern recognition receptors recognize these microbial signals and help develop interaction
between host and microbe (Mogensen, 2009). The role of epithelial cells in maintaining microbiota
and host interaction is also significant. It maintains tolerance for commensal bacteria and offers a
reduction in response to a pathogen (Ignacio et al., 2016). The intestinal homeostasis functions to
control the penetration of bacteria through the epithelial barrier, and innate immune strategies
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prevent bacteria from colonization in small intestine epithelial cells. The most commonly used
natural processes for this function are antimicrobial peptide and mucus production (Huttenhower
et al., 2012). Comparison of the gut microbiota in the conventionally raised chickens with germ
free broiler chickens has also shown that gut microbiota is crucial for the development of chickens
as SCFA increases enterocyte development in the chicken body (Chambers & Gong, 2011).
Moreover, it is an essential source of crucial nutrients, including ammonium, vitamins, and some
types of amino acids (Pan & Yu, 2014). The microbiota produces essential nutrients such
as vitamins (B and K groups), organic acids like lactic acid, and short chain fatty acids
(acetic, butyric, and propionic acid) as well as antimicrobial compounds like bacteriocins. So,
microbiota is not only essential for maintaining immune homeostasis but also in providing
nutrients necessary for growth (Shang et al., 2018).
1.3.1

Microbiota and pathogens
The association between gut microbiota and susceptibility to infection by pathogens was

first shown by Adams and Prince (1959), who showed that mice free from gut microbes were
more susceptible to the pathogen infection than mice with a strong microbiota community. It is
widely accepted by scientists that early colonization of the gut by bacteria is important for the
well-being and productivity of chickens, as it can modify the digestive tract shape and function as
well as its influencing susceptibility of their hosts to various infectious diseases. The colonization
of the GIT of birds is followed by the microbial population enrichment and increase in complexity
and diversity of these bacterial communities. This is then followed by the maturation and
stabilization of the microbial communities. The whole process normally takes around three weeks
after hatching of the broiler chickens (Diaz Carrasco et al., 2019). The microbial communities or
the microbiota that develops and matures in the GIT protects its host from various pathogens in
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various ways. This includes adjusting pH values to create acidic environments or change
oxygenation levels in the GIT to make it harder for pathogens that have certain pH and oxygen
level requirements to colonize in the host’s GIT (Kalliomäki & Walker, 2005; Marteyn et al.,
2011). Moreover, as the microbiota is highly adaptable to its host’s environment, the foreign
pathogens that enter into a new niche in the host face difficulty in competing with the indigenous
microbiota for nutrients and other resources (Lawley & Walker, 2013). Furthermore, the gut
microbiota also produce secondary metabolites that inhibit the growth of foreign pathogens, which
in combination with the stimulation the host innate and adaptive immune response by microbiota,
serves as to clear the foreign pathogenic bacteria from the host’s body (Han et al., 2017). The gut
microbiota not only protects from infection in the GIT by bacteria, fungi, and viruses, but also
impacts susceptibility to infections in various other organs such as brain, lungs, liver, and skin
(Abaidullah et al., 2019). Because of these reasons, the role of chicken gut microbiota is important
in maintaining health and protect the host from infections by pathogens. However, due to
variability in chickens and their flocks, pinpointing the exact molecular mechanisms induced by
the gut microbiota that has beneficial effect on chicken health and on protection against pathogenic
bacteria has been difficult (Diaz Carrasco et al., 2019). Therefore, extensive research is required
to understand the physiological roles and molecular dynamics of microbiota (Abaidullah et al.,
2019).
1.3.2

Microbiota and C. jejuni
One of the most important factors in the colonization of chicken GIT by C. jejuni has been

shown to be the intestinal microbiota of chickens (Han et al., 2017). A healthy balanced microbial
community in chickens is dominated by beneficial gram-positive bacteria (at least 85
percent), while

the

remaining

bacteria

include
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Clostridium

in

younger

birds,

and

Campylobacter, Escherichia coli, and Salmonella in older birds in absence of any intestinal
disturbance (Choct, 2009). It is unclear how much the microbiota in the chicken GIT influences
the colonization by C. jejuni. The antibiotic treated and germ free chicken have been shown to be
susceptible to C. jejuni colonization at significantly higher levels than chicken reared in more
conventional farming systems. This highlights a role of natural chicken microbiota in conferring
resistance against C. jejuni infection in chickens (Han et al., 2017). A study by Han et al. (2017)
has shown that microbiota depletion in chicken due to the antibiotic treatment and germ-free
rearing conditions increases the CFU of C. jejuni in chickens. The authors of the study speculated
that lower intestinal diversity allows for the initial colonization of the chicken GIT by C. jejuni.
Once initial colonization is complete, the resident C. jejuni reduce the intestinal integrity of
chicken which paves a way for more C. jejuni to breach the intestinal barrier. This allows greater
number of C. jejuni to colonize the GIT, which in absence of diverse and rich intestinal microbiota
can spread to other organs as well due to compromised intestinal integrity. Still, not much is known
about the specific gut microbes that help in competitive exclusion of C. jejuni or the bacteria that
help C. jejuni to successfully colonize the chicken GIT (Deng et al., 2020). Experimental evidence
exists for the association between high levels of Clostridium perfringens (C. perfringens) and
increased susceptibility to C. jejuni colonization in chicken (Skånseng et al., 2006). On the other
hand, high prevalence of Actinobacteria in chickens has been found to be associated with reduced
C. jejuni colonization (Kaakoush et al., 2014). In mouse models, Bifidobacterium, Clostridium
cluster XI, and Lactobacilli have been shown to have a protective role against C. jejuni
colonization. Moreover, depletion of the gut microbes induced by antibiotics usage has been shown
to contribute to C. jejuni colonization and development of enteritis in mice (O'Loughlin et al.,
2015; Sun, Jia, et al., 2018).
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1.3.3

Microbial metabolites and C. jejuni
The host-microbiota helps strengthen the host immune system and produces metabolites

and nutrients that help improve the host growth rate. Generally, gut microbiota produces two types
of metabolites: primary and secondary. Primary metabolites consisting of peptides,
polysaccharides, and fatty acids are functional in every biological system. These metabolites are
involved in production of SCFAs and vitamins by fermenting non-digestible components of the
digestive system. Both the SCFAs and vitamins have been shown to aid in the growth of the host
and also maintaining an effect on intestinal immune homeostasis (Bäckhed et al., 2005; Guarner
& Malagelada, 2003). The secondary metabolites of gut microbiota are diverse compounds all of
which are characterized by low molecular weight (i.e., around 3000 Daltons). They are functional
only in specific biological processes in an organism. These secondary metabolites that are isolated
from gut microbes that have antimicrobial properties are known as bacteriocins (Bérdy, 2005;
Zacharof & Lovitt, 2012). The major difference between antibiotics and bacteriocins is that the
former has broader spectrum activity while the activity of the latter is restricted mostly to strains
belonging to same species (Zacharof & Lovitt, 2012). The production of bacteriocins is also crucial
for containing C. jejuni population (Fu et al., 2021). Besides acting as antimicrobials, these
metabolites have a crucial role in growth processes, cell replication, and other responding actions
(Bérdy, 2005). These microbiota metabolites have also been demonstrated to suppress C. jejuni
growth by indirect antagonism against these bacteria (Blaut & Clavel, 2007; Holmes et al., 2011).
One of the most important products of microbiota are bile acids. More than 95% of bile
acids produced secreted into gut are successfully absorbed in the gut (Ridlon et al., 2006). In the
hepatocytes, primary bile acids like chenodeoxycholic acid (CDCA) and cholic acid (CA) are
produced from cholesterol, which are then conjugated with glycine or taurine (Chiang, 2004).
Inside the intestine, bile salt hydrolase (BSH) are produced by bacteria which deconjugate
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conjugated primary bile acids, which are then changed by microbiota to form secondary bile acids
such as lithocholic acid (LCA), ursodeoxycholic acid (UDCA) and deoxycholic acid (DCA)
(Archer et al., 1982; Gilliland & Speck, 1977; Ridlon et al., 2006). Bile acids have been linked to
a number of chronic disorders, but current research has given indication of positive properties of
secondary bile acids in promoting health and ameliorating diseases, such as enhancing gut motility.
Anaerobic microbiota as well as their metabolite DCA protects chickens and mice from the C.
jejuni colonization (Alrubaye et al., 2019) and intestinal inflammation, respectively (Bansal et al.,
2020). Recent studies have revealed that DCA alters microbiota composition in chickens to
prevent C. jejuni colonization (Alrubaye et al., 2019). It increases the population of phylum
Bacteroidetes in chicken cecal microbiota and decreases Firmicutes population, which might be
responsible for conferring protection against C. jejuni infection (Alrubaye et al., 2019). The
particular commensal microbiota composition of the host gut determines vulnerability to C. jejuni
infection. This has been demonstrated in the conventionally colonized wild type mice, which are
immune to the colonization and infection by C. jejuni colonization even after high C. jejuni peroral
infection doses (Heimesaat et al., 2019b). Recent findings suggest that some anaerobic bacteria
and the metabolites (specifically DCA) protect Il10-/- mice from the intestinal inflammation caused
by C. jejuni. These metabolites as well as the signaling cascades they induce are important events
in controlling C jejuni infections and thus, may define new treatment targets (Sun et al., 2018).
1.3.4

The role of mouse microbiota against C. jejuni
Research on understanding the role of host microbiota in colonization resistance against C.

jejuni and the biological processes that allow C. jejuni to colonize and causes disease symptoms
in the hosts was hampered for long due to the lack of appropriate in vivo models. However,
recently, a number of mice models have been developed that have shed light on this
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topic (Giallourou et al., 2018; Heimesaat et al., 2019a, 2019b; Sun, Winglee, et al., 2018; Wang
et al., 2019). Mice gut microbiota contain a total of 37 genera (Wang et al., 2019). Among all these
bacteria, only eight bacteria namely, Bifidobacterium, Butyricoccus, Clostridium XI,
Coprobacillus, Hydrogenoanaerobacterium, Lactobacillus, Oscillibacter, and Roseburia, are
found to confer resistance to C. jejuni colonization in mice (Sun, Winglee, et al., 2018). On the
other hand, high numbers of E. coli have been shown to facilitate C. jejuni colonization while
enrichment of Enterococcus spp. and Clostridium sensu stricto in the mice microbiota has been
shown to facilitate colitis induced by C. jejuni (Haag et al., 2012; Sun, Winglee, et al., 2018).
Specific pathogen free (SPF) mice have been shown to be naturally resistant to the
colonization of C. jejuni. On the other hand, birds show one of the highest colonization rates of C.
jejuni colonization albeit without development of any visible disease symptoms most of the time
(Awad et al., 2018; Sun, Winglee, et al., 2018). Humans show one of the strongest responses to C.
jejuni colonization due to the development of various disease symptoms which normally go away
on their own in 1 to 2 weeks (Giallourou et al., 2018). The specific reason for this heterogeneity
in C. jejuni colonization rates and responses by different hosts is unknown. One of the most
probable reason for these different outcomes could be the difference in microbiota and specially
gut microbiota between these organisms (Lawley & Walker, 2013). Mice gut microbiota acts as a
protective shield against colonization of C. jejuni as shown by studies using conventionally raised
mice and gnotobiotic and germ free (GF) mice. The former murine models successfully repel C.
jejuni colonization while in the latter two groups, C. jejuni has been shown to easily colonize the
mice (Bereswill et al., 2011; Smith & Tucker, 1978). Further evidence on the role of mice
microbiota in protecting the host from C. jejuni colonization comes from antibiotic treated (AT)
mice models. Administration of ampicillin in mice decreases bacterial diversity which has been
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found to be correlated with increased susceptibility to C. jejuni colonization (O'Loughlin et al.,
2015). Moreover, reconstitution of the mice microbiota with human microbiota has been shown to
allow C. jejuni colonization in mice while the opposite has been found to be true when mice are
reconstituted with mice microbiota (Bereswill et al., 2011). Furthermore, a recent study by
Heimesaat et al. (2019b) has shown that mice containing high loads of C. jejuni due to depleted
microbiota and C. jejuni infection could be successfully treated with FMT from healthy and
conventionally raised mice. The authors showed that FMT treatment reduced the C. jejuni loads
in mice by 7.5 folds within two weeks. Moreover, C. jejuni cells were even completely eliminated
in 12.5% of mice that previously contained high numbers of C. jejuni. Besides, the FMT treatment
also improved immune response and reversed the intestinal damage caused by the C. jejuni
colonization in mice. In another study, Heimesaat et al. (2019a) also showed that FMT treatment
could also treat mice model of human C. jejuni infection. This was demonstrated by two fold
decrease in C. jejuni cells load and improvement in immune status in the human C. jejuni infection
mice models within a week of FMT.
There is presently relatively little data on supporting the use of FMT to prevent C. jejuni
colonization in chickens. However, in humans, the generation of bile acids by FMT has been
shown to be highly efficient in treating reoccurring Clostridium difficile infections (Buffie et al.,
2015; Silverman et al., 2010). However, there is lack of date that support the usage of mice
microbiota to prevent C. jejuni chicken colonization. In the next chapter, we used SPF-mice
microbiota to prevent C. jejuni chicken colonization.
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Figure 1.1

Microbiota and microbial metabolites illustration of inhibition C. jejuni in gut.

26

1.4

References

Abaidullah, M., Peng, S., Kamran, M., Song, X., & Yin, Z. (2019). Current Findings on Gut
Microbiota Mediated Immune Modulation against Viral Diseases in Chicken. Viruses,
11(8), 681. https://www.mdpi.com/1999-4915/11/8/681
Acheson, D., & Allos, B. M. J. C. i. d. (2001). Campylobacter jejuni infections: update on
emerging issues and trends. 32(8), 1201-1206.
Adams, W. R., & Prince, A. M. J. A. o. t. N. Y. A. o. S. (1959). Cellular changes associated with
infection of the Ehrlich ascites tumor with Newcastle disease virus. 81(1), 89-100.
Adkin, A., Hartnett, E., Jordan, L., Newell, D., & Davison, H. J. J. o. A. M. (2006). Use of a
systematic review to assist the development of Campylobacter control strategies in broilers.
100(2), 306-315.
Ahmad, R. S., Imran, A., & Hussain, M. B. (2018). Nutritional composition of meat. Meat science
and nutrition, 61(10.5772). https://doi.org/10.5772/intechopen.77045
Ahmed, M., Schulz, J., & Hartung, J. J. P. s. (2013). Survival of Campylobacter jejuni in naturally
and artificially contaminated laying hen feces. 92(2), 364-369.
Alrubaye, B., Abraha, M., Almansour, A., Bansal, M., Wang, H., Kwon, Y. M., Huang, Y., Hargis,
B., & Sun, X. (2019). Microbial metabolite deoxycholic acid shapes microbiota against
Campylobacter jejuni chicken colonization. PloS one, 14(7), e0214705.
https://doi.org/10.1371/journal.pone.0214705
Archer, R., Chong, R., Maddox, I. J. E. j. o. a. m., & biotechnology. (1982). Hydrolysis of bile
acid conjugates by Clostridium bifermentans. 14(1), 41-45.
Arsi, K., Donoghue, A. M., Woo-Ming, A., Blore, P. J., & Donoghue, D. J. (2015). The efficacy
of selected probiotic and prebiotic combinations in reducing Campylobacter colonization
in broiler chickens. Journal of Applied Poultry Research, 24(3), 327-334.
https://doi.org/10.3382/japr/pfv032
Awad, W. A., Dublecz, F., Hess, C., Dublecz, K., Khayal, B., Aschenbach, J. R., & Hess, M.
(2016). Campylobacter jejuni colonization promotes the translocation of Escherichia coli
to extra-intestinal organs and disturbs the short-chain fatty acids profiles in the chicken gut.
Poultry Science, 95(10), 2259-2265. https://doi.org/https://doi.org/10.3382/ps/pew151
Awad, W. A., Hess, C., & Hess, M. (2018). Re-thinking the chicken–Campylobacter jejuni
interaction:
a
review.
Avian
Pathology,
47(4),
352-363.
https://doi.org/10.1080/03079457.2018.1475724
Awad, W. A., Molnár, A., Aschenbach, J. R., Ghareeb, K., Khayal, B., Hess, C., Liebhart, D.,
Dublecz, K., & Hess, M. (2015). Campylobacter infection in chickens modulates the
intestinal epithelial barrier function. Innate Immunity, 21(2), 151-160.
https://doi.org/10.1177/1753425914521648
27

Bäckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A., & Gordon, J. I. J. s. (2005). Hostbacterial mutualism in the human intestine. 307(5717), 1915-1920.
Balfour, J. A., & Faulds, D. J. P. (1993). Oral ciprofloxacin. 3(5), 398-421.
Ballou, A. L., Ali, R. A., Mendoza, M. A., Ellis, J., Hassan, H. M., Croom, W., & Koci, M. D. J.
F. i. v. s. (2016). Development of the chick microbiome: how early exposure influences
future microbial diversity. 3, 2.
Bansal, M., Fu, Y., Alrubaye, B., Abraha, M., Almansour, A., Gupta, A., Liyanage, R., Wang, H.,
Hargis, B., & Sun, X. (2020). A secondary bile acid from microbiota metabolism attenuates
ileitis and bile acid reduction in subclinical necrotic enteritis in chickens. Journal of Animal
Science and Biotechnology, 11(1), 37. https://doi.org/10.1186/s40104-020-00441-6
Bassler, B. L., Wright, M., & Silverman, M. R. (1994). Multiple signalling systems controlling
expression of luminescence in Vibrio harveyi: sequence and function of genes encoding a
second
sensory
pathway.
Molecular
Microbiology,
13(2),
273-286.
https://doi.org/https://doi.org/10.1111/j.1365-2958.1994.tb00422.x
Beery, J., Hugdahl, M., & Doyle, M. (1988). Colonization of gastrointestinal tracts of chicks by
Campylobacter jejuni. Applied and environmental microbiology, 54(10), 2365-2370.
https://doi.org/10.1128/aem.54.10.2365-2370.1988
Bérdy, J. (2005). Bioactive microbial metabolites. 58(1), 1-26. https://doi.org/10.1038/ja.2005.1
Bereswill, S., Fischer, A., Plickert, R., Haag, L.-M., Otto, B., Kühl, A. A., Dashti, J. I., Zautner,
A. E., Muñoz, M., Loddenkemper, C., Groß, U., Göbel, U. B., & Heimesaat, M. M. (2011).
Novel Murine Infection Models Provide Deep Insights into the “Ménage à Trois” of
Campylobacter jejuni, Microbiota and Host Innate Immunity. PLOS ONE, 6(6), e20953.
https://doi.org/10.1371/journal.pone.0020953
Bhaduri, S., & Cottrell, B. (2004). Survival of cold-stressed Campylobacter jejuni on ground
chicken and chicken skin during frozen storage. Applied and Environmental Microbiology,
70(12), 7103-7109.
Blaut, M., & Clavel, T. J. T. J. o. n. (2007). Metabolic diversity of the intestinal microbiota:
implications for health and disease. 137(3), 751S-755S.
Bolton, D. J. (2015). Campylobacter virulence and survival factors. Food Microbiology, 48, 99108. https://doi.org/10.1016/j.fm.2014.11.017
Bolton, F., Hutchinson, D., & Coates, D. (1984). Blood-free selective medium for isolation of
Campylobacter jejuni from feces. Journal of clinical microbiology, 19(2), 169-171.
https://doi.org/10.1128/jcm.19.2.169-171.1984
Bolton, F. J., & Robertson, L. (1982). A selective medium for isolating Campylobacter jejuni/coli.
Journal of clinical pathology, 35(4), 462-467. https://doi.org/10.1136/jcp.35.4.462

28

Buffie, C. G., Bucci, V., Stein, R. R., McKenney, P. T., Ling, L., Gobourne, A., No, D., Liu, H.,
Kinnebrew, M., & Viale, A. (2015). Precision microbiome reconstitution restores bile acid
mediated resistance to Clostridium difficile. Nature, 517(7533), 205-208.
Burnham, P. M., & Hendrixson, D. R. (2018). Campylobacter jejuni: collective components
promoting a successful enteric lifestyle. Nature Reviews Microbiology, 16(9), 551-565.
https://doi.org/10.1038/s41579-018-0037-9
Castillo, S., Heredia, N., Arechiga-Carvajal, E., & García, S. (2014). Citrus Extracts as Inhibitors
of Quorum Sensing, Biofilm Formation and Motility of Campylobacter jejuni. Food
Biotechnology, 28(2), 106-122. https://doi.org/10.1080/08905436.2014.895947
CDC.

(2019).
2019
AR
Threats
Report.
Retrieved
https://www.cdc.gov/drugresistance/biggest-threats.html

CDC.

(2021).
Campylobacter
https://www.cdc.gov/campylobacter/index.html

26/12//

from

(Campylobacteriosis).

Chaloner, G., Wigley, P., Humphrey, S., Kemmett, K., Lacharme-Lora, L., Humphrey, T.,
Williams, N., & Schaffner, D. W. (2014). Dynamics of Dual Infection with Campylobacter
jejuni Strains in Chickens Reveals Distinct Strain-to-Strain Variation in Infection Ecology.
Applied
and
Environmental
Microbiology,
80(20),
6366-6372.
https://doi.org/10.1128/AEM.01901-14
Chambers, J. R., & Gong, J. J. F. R. I. (2011). The intestinal microbiota and its modulation for
Salmonella control in chickens. 44(10), 3149-3159.
Chamovitz, B. N., Hartstein, A. I., Alexander, S. R., Terry, A. B., Short, P., & Katon, R. J. P.
(1983). Campylobacter jejuni-associated hemolytic-uremic syndrome in a mother and
daughter. 71(2), 253-256. https://doi.org/10.1542/peds.71.2.253
Chiang, J. Y. L. (2004). Regulation of bile acid synthesis: pathways, nuclear receptors, and
mechanisms.
Journal
of
hepatology,
40(3),
539-551.
https://doi.org/10.1016/j.jhep.2003.11.006
Chmielewski, R. A. N., & Frank, J. F. (2003). Biofilm Formation and Control in Food Processing
Facilities. Comprehensive Reviews in Food Science and Food Safety, 2(1), 22-32.
https://doi.org/https://doi.org/10.1111/j.1541-4337.2003.tb00012.x
Choct, M. (2009). Managing gut health through nutrition. British Poultry Science, 50(1), 9-15.
https://doi.org/10.1080/00071660802538632
Cogliani, C., Goossens, H., & Greko, C. (2011). Restricting antimicrobial use in food animals:
lessons from Europe. Microbe, 6(6), 274.
Coker, A. O., Isokpehi, R. D., Thomas, B. N., Amisu, K. O., & Obi, C. L. J. E. i. d. (2002). Human
campylobacteriosis
in
developing
countries1.
8(3),
237.
https://doi.org/10.3201/eid0803.010233
29

Condran, G. A., & Murphy, J. (2008). Defining and Managing Infant Mortality: A Case Study of
Philadelphia,
1870–1920.
Social
Science
History,
32(4),
473-513.
https://doi.org/10.1017/S0145553200010804
Cox, N. A., Hofacre, C. L., Bailey, J. S., Buhr, R. J., Wilson, J. L., Hiett, K. L., Richardson, L. J.,
Musgrove, M. T., Cosby, D. E., Tankson, J. D., Vizzier, Y. L., Cray, P. F., Vaughn, L. E.,
Holt, P. S., & Bourassa, D. V. (2005). Presence of Campylobacter jejuni in Various Organs
One Hour, One Day, and One Week Following Oral or Intracloacal Inoculations of Broiler
Chicks. Avian Diseases, 49(1), 155-158, 154. https://doi.org/10.1637/7234-070704R
Deng, W., Dittoe, D. K., Pavlidis, H. O., Chaney, W. E., Yang, Y., & Ricke, S. C. (2020). Current
Perspectives and Potential of Probiotics to Limit Foodborne Campylobacter in Poultry.
Frontiers in Microbiology, 11, 2989. https://doi.org/10.3389/fmicb.2020.583429
Dhama, K., Chakraborty, S., Kapoor, S., Tiwari, R., Kumar, A., Deb, R., Rajagunalan, S., Singh,
R., Vora, K., & Natesan, S. J. A. A. V. S. (2013). One world, one health-veterinary
perspectives. 1(1), 5-13.
Diaz Carrasco, J. M., Casanova, N. A., & Fernández Miyakawa, M. E. (2019). Microbiota, Gut
Health and Chicken Productivity: What Is the Connection? Microorganisms, 7(10), 374.
https://www.mdpi.com/2076-2607/7/10/374
Djenane, D., Yangüela, J., Amrouche, T., Boubrit, S., Boussad, N., Roncalés, P. J. F. S., &
International, T. (2011). Chemical composition and antimicrobial effects of essential oils
of Eucalyptus globulus, Myrtus communis and Satureja hortensis against Escherichia coli
O157: H7 and Staphylococcus aureus in minced beef. 17(6), 505-515.
EFSA. (2020). The European Union Summary Report on Antimicrobial Resistance in zoonotic
and indicator bacteria from humans, animals and food in 2017/2018. EFSA journal.
European
Food
Safety
Authority,
18(3),
e06007-e06007.
https://doi.org/10.2903/j.efsa.2020.6007
Elhadidy, M., Miller, W. G., Arguello, H., Álvarez-Ordóñez, A., Duarte, A., Dierick, K., &
Botteldoorn, N. (2018). Genetic Basis and Clonal Population Structure of Antibiotic
Resistance in Campylobacter jejuni Isolated From Broiler Carcasses in Belgium [Original
Research]. Frontiers in Microbiology, 9(1014). https://doi.org/10.3389/fmicb.2018.01014
Es-Soucratti, K., Hammoumi, A., Bouchrif, B., Asmai, R., En-Nassiri, H., & Karraouan, B. (2020).
Occurrence and antimicrobial resistance of Campylobacter jejuni isolates from poultry in
Casablanca-Settat, Morocco. Italian journal of food safety, 9(1), 8692-8692.
https://doi.org/10.4081/ijfs.2020.8692
Escherich, T. (1886). Beitrage zur Kenntniss der Darmbacterien. III. Ueber das Vorkommen von
Vibrionen im Darmcanal und den Stuhlgangen der Sauglinge.(Articles adding to the
knowledge of intestinal bacteria. III. On the existence of vibrios in the intestines and feces
of babies.) Münchener Med Wochenschrift, 33, 815-817.

30

Feye, K. M., Baxter, M. F. A., Tellez-Isaias, G., Kogut, M. H., & Ricke, S. C. (2020). Influential
factors on the composition of the conventionally raised broiler gastrointestinal
microbiomes. Poultry Science, 99(2), 653-659. https://doi.org/10.1016/j.psj.2019.12.013
Fields, P. I., & Swerdlow, D. L. J. C. i. l. m. (1999). Campylobacter jejuni. 19(3), 489-504.
Fitzenberger, J., Uphoff, H., Gawrich, S., & Hauri, A. J. E. (2010). Urban–rural differences of ageand species-specific campylobacteriosis incidence, Hesse, Germany, July 2005–June 2006.
15(42), 19693. https://doi.org/10.2807/ese.15.42.19693-en
Fu, Y., Alenezi, T., Almansour, A., Wang, H., Jia, Z., & Sun, X. (2021). The Role of Immune
Response and Microbiota on Campylobacteriosis. In Campylobacter. IntechOpen.
https://doi.org/10.5772/intechopen.96755
Gálvez, A., Abriouel, H., López, R. L., & Omar, N. B. (2007). Bacteriocin-based strategies for
food biopreservation. International Journal of Food Microbiology, 120(1), 51-70.
https://doi.org/10.1016/j.ijfoodmicro.2007.06.001
Gantois, I., Ducatelle, R., Pasmans, F., Haesebrouck, F., Gast, R., Humphrey, T. J., & Van
Immerseel, F. J. F. m. r. (2009). Mechanisms of egg contamination by Salmonella
Enteritidis. 33(4), 718-738.
Gharst, G., Oyarzabal, O. A., & Hussain, S. K. (2013). Review of current methodologies to isolate
and identify Campylobacter spp. from foods. Journal of Microbiological Methods, 95(1),
84-92. https://doi.org/https://doi.org/10.1016/j.mimet.2013.07.014
Giallourou, N., Medlock, G. L., Bolick, D. T., Medeiros, P. H. Q. S., Ledwaba, S. E., Kolling, G.
L., Tung, K., Guerry, P., Swann, J. R., & Guerrant, R. L. (2018). A novel mouse model of
Campylobacter jejuni enteropathy and diarrhea. PLOS Pathogens, 14(3), e1007083.
https://doi.org/10.1371/journal.ppat.1007083
Gilliland, S. E., & Speck, M. L. (1977). Deconjugation of bile acids by intestinal lactobacilli.
Applied
and
environmental
microbiology,
33(1),
15-18.
https://doi.org/10.1128/aem.33.1.15-18.1977
Green, C. G., Krause, D. O., & Wylie, J. L. J. I. J. o. H. G. (2006). Spatial analysis of
campylobacter infection in the Canadian province of Manitoba. 5(1), 1-14.
https://doi.org/10.1186/1476-072X-5-2
Guarner, F., & Malagelada, J.-R. J. T. L. (2003). Gut flora in health and disease. 361(9356), 512519.
Guyard-Nicodème, M., Rivoal, K., Houard, E., Rose, V., Quesne, S., Mourand, G., Rouxel, S.,
Kempf, I., Guillier, L., Gauchard, F., & Chemaly, M. (2015). Prevalence and
characterization of Campylobacter jejuni from chicken meat sold in French retail outlets.
International
Journal
of
Food
Microbiology,
203,
8-14.
https://doi.org/https://doi.org/10.1016/j.ijfoodmicro.2015.02.013

31

Haag, L.-M., Fischer, A., Otto, B., Plickert, R., Kühl, A. A., Göbel, U. B., Bereswill, S., &
Heimesaat, M. M. (2012). Intestinal Microbiota Shifts towards Elevated Commensal
Escherichia coli Loads Abrogate Colonization Resistance against Campylobacter jejuni in
Mice. PLOS ONE, 7(5), e35988. https://doi.org/10.1371/journal.pone.0035988
Han, Z., Li, L., Willer, T., Baumgärtner, W., & Rautenschlein, S. (2020). Adhesion and invasion
of Campylobacter jejuni in chickens with a modified gut microbiota due to antibiotic
treatment.
Veterinary
Microbiology,
240,
108504.
https://doi.org/10.1016/j.vetmic.2019.108504
Han, Z., Willer, T., Li, L., Pielsticker, C., Rychlik, I., Velge, P., Kaspers, B., & Rautenschlein, S.
(2017). Influence of the gut microbiota composition on Campylobacter jejuni colonization
in
chickens.
Infection
and
immunity,
85(11),
e00380-00317.
https://doi.org/10.1128/IAI.00380-17
Hansson, I. (2007). Bacteriological and epidemiological studies of campylobacter spp. in Swedish
broilers (Vol. 2007).
Hara-Kudo, Y., & Takatori, K. (2011). Contamination level and ingestion dose of foodborne
pathogens associated with infections. Epidemiology and Infection, 139(10), 1505-1510.
https://doi.org/10.1017/S095026881000292X
Hassan, W. M., Mekky, A., & Enany, M. (2019). Review on some virulence factors associated
with Campylobacter colonization and infection in poultry and human. American Journal
of
Biomedical
Science
&
Research,
3,
460-463.
https://doi.org/10.34297/AJBSR.2019.03.000717
Havelaar, A. H., Kirk, M. D., Torgerson, P. R., Gibb, H. J., Hald, T., Lake, R. J., Praet, N.,
Bellinger, D. C., De Silva, N. R., & Gargouri, N. (2015). World Health Organization global
estimates and regional comparisons of the burden of foodborne disease in 2010. PLoS
medicine, 12(12), e1001923.
Hazards, E. P. o. B. (2010). Scientific opinion on quantification of the risk posed by broiler meat
to human campylobacteriosis in the EU. EFSA Journal, 8(1), 1437.
Hazeleger, W. C., Wouters, J. A., Rombouts, F. M., & Abee, T. (1998). Physiological Activity of
Campylobacter jejuni Far below the Minimal Growth Temperature. Applied and
Environmental
Microbiology,
64(10),
3917-3922.
https://doi.org/10.1128/AEM.64.10.3917-3922.1998
Heimesaat, M. M., Mrazek, K., & Bereswill, S. (2019a). Murine Fecal Microbiota Transplantation
Alleviates Intestinal and Systemic Immune Responses in Campylobacter jejuni Infected
Mice Harboring a Human Gut Microbiota [Original Research]. Frontiers in Immunology,
10(2272). https://doi.org/10.3389/fimmu.2019.02272

32

Heimesaat, M. M., Mrazek, K., & Bereswill, S. (2019b). Murine fecal microbiota transplantation
lowers gastrointestinal pathogen loads and dampens pro-inflammatory immune responses
in Campylobacter jejuni infected secondary abiotic mice. Scientific Reports, 9(1), 19797.
https://doi.org/10.1038/s41598-019-56442-7
Hermans, D., Van Deun, K., Martel, A., Van Immerseel, F., Messens, W., Heyndrickx, M.,
Haesebrouck, F., & Pasmans, F. (2011). Colonization factors of Campylobacter jejuni in
the chicken gut. Veterinary research, 42(1), 1-14.
Hodgins, D. C., Barjesteh, N., St. Paul, M., Ma, Z., Monteiro, M. A., & Sharif, S. (2015).
Evaluation of a polysaccharide conjugate vaccine to reduce colonization by Campylobacter
jejuni in broiler chickens. BMC Research Notes, 8(1), 204. https://doi.org/10.1186/s13104015-1203-z
Hoffmann, S., Ashton, L., Todd, E., Jessica, E., Ahn, J.-w., & Berck, P. (2021). Attributing U.S.
Campylobacteriosis Cases to Food Sources, Season, and
Temperature.
U.S
Department
of
Agriculture.
Retrieved
https://www.ers.usda.gov/webdocs/publications/100501/err-284.pdf

26/12//

from

Holmes, E., Li, J. V., Athanasiou, T., Ashrafian, H., & Nicholson, J. K. J. T. i. m. (2011).
Understanding the role of gut microbiome–host metabolic signal disruption in health and
disease. 19(7), 349-359.
Hooper, L. V., & Gordon, J. I. J. S. (2001). Commensal host-bacterial relationships in the gut.
292(5519), 1115-1118.
Horrocks, S., Anderson, R., Nisbet, D., & Ricke, S. J. A. (2009). Incidence and ecology of
Campylobacter jejuni and coli in animals. 15(1-2), 18-25.
Howlett, R. M., Davey, M. P., Paul Quick, W., & Kelly, D. J. (2014). Metabolomic analysis of the
food-borne pathogen Campylobacter jejuni: application of direct injection mass
spectrometry for mutant characterisation. Metabolomics, 10(5), 887-896.
https://doi.org/10.1007/s11306-014-0644-z
Humphrey, S., Lacharme-Lora, L., Chaloner, G., Gibbs, K., Humphrey, T., Williams, N., &
Wigley, P. (2015). Heterogeneity in the Infection Biology of Campylobacter jejuni Isolates
in Three Infection Models Reveals an Invasive and Virulent Phenotype in a ST21 Isolate
from
Poultry.
PLOS
ONE,
10(10),
e0141182.
https://doi.org/10.1371/journal.pone.0141182
Huttenhower, C., Gevers, D., Knight, R., Abubucker, S., Badger, J. H., Chinwalla, A. T., Creasy,
H. H., Earl, A. M., FitzGerald, M. G., & Fulton, R. S. J. n. (2012). Structure, function and
diversity of the healthy human microbiome. 486(7402), 207.
Ignacio, A., Morales, C. I., Câmara, N. O. S., & Almeida, R. R. J. F. i. i. (2016). Innate sensing of
the gut microbiota: modulation of inflammatory and autoimmune diseases. 7, 54.

33

Jeon, B., Itoh, K., Misawa, N., Ryu, S. J. M., & immunology. (2003). Effects of quorum sensing
on flaA transcription and autoagglutination in Campylobacter jejuni. 47(11), 833-839.
Johnson, T. J., Shank, J. M., & Johnson, J. G. (2017). Current and Potential Treatments for
Reducing Campylobacter Colonization in Animal Hosts and Disease in Humans [Review].
Frontiers in Microbiology, 8(487). https://doi.org/10.3389/fmicb.2017.00487
Kaakoush, N. O., Sodhi, N., Chenu, J. W., Cox, J. M., Riordan, S. M., & Mitchell, H. M. (2014).
The interplay between Campylobacter and Helicobacter species and other gastrointestinal
microbiota of commercial broiler chickens. Gut Pathogens, 6(1), 18.
https://doi.org/10.1186/1757-4749-6-18
Kalliomäki, M. A., & Walker, W. A. (2005). Physiologic and Pathologic Interactions of Bacteria
with Gastrointestinal Epithelium. Gastroenterology Clinics of North America, 34(3), 383399. https://doi.org/10.1016/j.gtc.2005.05.007
Kist, M. (1985). The historical background of Campylobacter infection: new aspects. Proceedings
of the 3rd International Workshop on Campylobacter Infections,
Kittler, S., Fischer, S., Abdulmawjood, A., Glünder, G., & Klein, G. (2014). Colonisation of a
Phage Susceptible Campylobacter jejuni Population in Two Phage Positive Broiler Flocks.
PLOS ONE, 9(4), e94782. https://doi.org/10.1371/journal.pone.0094782
Kizerwetter-Świda, M., Binek, M. J. J. o. A., & Sciences, F. (2008). Bacterial microflora of the
chicken embryos and newly hatched chicken. 17(2), 224-232.
Koningstein, M., Simonsen, J., Helms, M., Hald, T., & Mølbak, K. J. C. i. d. (2011). Antimicrobial
use: a risk factor or a protective factor for acquiring campylobacteriosis? , 53(7), 644-650.
Lamb-Rosteski, J. M., Kalischuk, L. D., Inglis, G. D., & Buret, A. G. (2008). Epidermal growth
factor inhibits Campylobacter jejuni-induced claudin-4 disruption, loss of epithelial barrier
function, and Escherichia coli translocation. Infection and immunity, 76(8), 3390-3398.
Lawley, T. D., & Walker, A. W. (2013). Intestinal colonization resistance. Immunology, 138(1),
1-11. https://doi.org/10.1111/j.1365-2567.2012.03616.x
Levy, S. B., FitzGerald, G. B., & Macone, A. B. (1976). Changes in intestinal flora of farm
personnel after introduction of a tetracycline-supplemented feed on a farm. New England
Journal of Medicine, 295(11), 583-588.
Lin, J. (2009). Novel approaches for Campylobacter control in poultry. Foodborne pathogens and
disease, 6(7), 755-765. https://doi.org/10.1089/fpd.2008.0247
Louis, V. R., Gillespie, I. A., O'Brien, S. J., Russek-Cohen, E., Pearson, A. D., Colwell, R. R. J.
A., & Microbiology, E. (2005). Temperature-driven Campylobacter seasonality in England
and Wales. 71(1), 85-92.

34

Lu, J., Idris, U., Harmon, B., Hofacre, C., Maurer, J. J., & Lee, M. D. (2003). Diversity and
succession of the intestinal bacterial community of the maturing broiler chicken. Applied
and
environmental
microbiology,
69(11),
6816-6824.
https://doi.org/10.1128/AEM.69.11.6816-6824.2003
Lu, T., Marmion, M., Ferone, M., Wall, P., & Scannell, A. G. M. (2021). On farm interventions to
minimise Campylobacter spp. contamination in chicken. British Poultry Science, 62(1),
53-67. https://doi.org/10.1080/00071668.2020.1813253
Man, S. M. (2011). The clinical importance of emerging Campylobacter species. Nature Reviews
Gastroenterology
&
Hepatology,
8(12),
669-685.
https://doi.org/10.1038/nrgastro.2011.191
Marshall, B. M., & Levy, S. B. (2011). Food Animals and Antimicrobials: Impacts on Human
Health.
Clinical
Microbiology
Reviews,
24(4),
718-733.
https://doi.org/doi:10.1128/CMR.00002-11
Marteyn, B., Scorza, F. B., Sansonetti, P. J., & Tang, C. (2011). Breathing life into pathogens: the
influence of oxygen on bacterial virulence and host responses in the gastrointestinal tract.
Cellular Microbiology, 13(2), 171-176. https://doi.org/10.1111/j.1462-5822.2010.01549.x
McFadyean, J., & Stockman, S. (1909). Epizootic Abortion in Cattle: Report of the Departmental
Committee Appointed by the Board of Agriculture and Fisheries to Inquire into Epizoo. tic
Abortion. Appendix to Part I., London, His Majesty's Stationery Office.
Mertins, S., Allan, B. J., Townsend, H. G., Köster, W., & Potter, A. A. (2012). Role of motAB in
Adherence and Internalization in Polarized Caco-2 Cells and in Cecal Colonization of
Campylobacter jejuni. Avian Diseases, 57(1), 116-122. https://doi.org/10.1637/10235050412-ResNote.1
Mogensen, T. H. J. C. m. r. (2009). Pathogen recognition and inflammatory signaling in innate
immune defenses. 22(2), 240-273.
Morooka, T., Umeda, A., & Amako, K. (1985). Motility as an intestinal colonization factor for
Campylobacter
jejuni.
Microbiology,
131(8),
1973-1980.
https://doi.org/10.1099/00221287-131-8-1973
Mughal, M. H. (2018). Campylobacteriosis-A Global Threat. Biomedical Journal of Scientific &
Technical Research, 11(5), 8804-8808. https://doi.org/10.26717/BJSTR.2018.11.002165
Murphy, C., Carroll, C., & Jordan, K. J. J. o. a. m. (2006). Environmental survival mechanisms of
the foodborne pathogen Campylobacter jejuni. 100(4), 623-632.
Murray, P., Baron, E., Jorgensen, J., Landry, M., Pfaller, M., & Stratton, C. J. C. I. D. (2008).
Manual of clinical microbiology: manual of clinical microbiology. 46, 153-154.

35

Nauta, M., Hill, A., Rosenquist, H., Brynestad, S., Fetsch, A., van der Logt, P., Fazil, A.,
Christensen, B., Katsma, E., Borck, B., & Havelaar, A. (2009). A comparison of risk
assessments on Campylobacter in broiler meat. International Journal of Food
Microbiology, 129(2), 107-123. https://doi.org/10.1016/j.ijfoodmicro.2008.12.001
Newell, D., Fearnley, C. J. A., & microbiology, e. (2003). Sources of Campylobacter colonization
in broiler chickens. 69(8), 4343-4351.
Nielsen, L. J. D. o. V. D. B. o. L. S. U. o. C., Surveillance, D. o. M., & Institut, R. S. S. (2010).
Interactions between Campylobacter and the human host [dissertation].
Nielsen, L. N. (2010). Interactions Between Campylobacter and the Human Host: PhD Thesis.
Department of Veterinary Disease Biology, University of Copenhagen.
Norström, M., Johnsen, G., Hofshagen, M., Tharaldsen, H., & Kruse, H. (2007). Antimicrobial
Resistance in Campylobacter jejuni from Broilers and Broiler House Environments in
Norway. Journal of Food Protection, 70(3), 736-738. https://doi.org/10.4315/0362-028x70.3.736
O'Loughlin, J. L., Samuelson, D. R., Braundmeier-Fleming, A. G., White, B. A., Haldorson, G. J.,
Stone, J. B., Lessmann, J. J., Eucker, T. P., Konkel, M. E., & Schloss, P. D. (2015). The
Intestinal Microbiota Influences Campylobacter jejuni Colonization and Extraintestinal
Dissemination in Mice. Applied and Environmental Microbiology, 81(14), 4642-4650.
https://doi.org/doi:10.1128/AEM.00281-15
OECD-FAO. (2021). Meat. Retrieved 12/24// from https://www.fao.org/3/CB5332EN/Meat.pdf
Pan, D., & Yu, Z. J. G. m. (2014). Intestinal microbiome of poultry and its interaction with host
and diet. 5(1), 108-119.
Parkhill, J., Wren, B., Mungall, K., Ketley, J., Churcher, C., Basham, D., Chillingworth, T.,
Davies, R., Feltwell, T., & Holroyd, S. J. N. (2000). The genome sequence of the foodborne pathogen Campylobacter jejuni reveals hypervariable sequences. 403(6770), 665668.
Pedroso, A., Menten, J., & Lambais, M. J. J. o. A. P. R. (2005). The structure of bacterial
community in the intestines of newly hatched chicks. 14(2), 232-237.
Penner, J. L. (1988). The genus Campylobacter: a decade of progress. Clinical microbiology
reviews, 1(2), 157-172.
Pitkänen, T., & Hänninen, M.-L. (2017). Members of the family Campylobacteraceae:
Campylobacter jejuni, Campylobacter coli. Global Water Pathogens Project. http://www.
waterpathogens. org Part 3 Specific excreted pathogens: environmental and epidemiology
aspects http://www. waterpathogens. org/book/campylobacter.
Plummer, P. (2012). LuxS and quorum-sensing in Campylobacter. Frontiers in cellular and
infection microbiology, 2, 22.
36

Quiñones, B., Miller, W. G., Bates, A. H., Mandrell, R. E. J. A., & microbiology, e. (2009).
Autoinducer-2 production in Campylobacter jejuni contributes to chicken colonization.
75(1), 281-285.
Ridlon, J. M., Kang, D.-J., & Hylemon, P. B. (2006). Bile salt biotransformations by human
intestinal
bacteria.
Journal
of
lipid
research,
47(2),
241-259.
https://doi.org/10.1194/jlr.R500013-JLR200
Rodríguez-Carpena, J. G., Morcuende, D., & Estévez, M. (2011). Avocado by-products as
inhibitors of color deterioration and lipid and protein oxidation in raw porcine patties
subjected
to
chilled
storage.
Meat
Science,
89(2),
166-173.
https://doi.org/10.1016/j.meatsci.2011.04.013
Roto, S. M., Kwon, Y. M., & Ricke, S. C. J. F. i. v. s. (2016). Applications of in ovo technique for
the optimal development of the gastrointestinal tract and the potential influence on the
establishment of its microbiome in poultry. 3, 63.
Sahin, O., Kassem, I. I., Shen, Z., Lin, J., Rajashekara, G., & Zhang, Q. (2015). Campylobacter in
poultry: ecology and potential interventions. Avian Diseases, 59(2), 185-200.
Salim, H. M., Huque, K. S., Kamaruddin, K. M., & Haque Beg, A. (2018). Global restriction of
using antibiotic growth promoters and alternative strategies in poultry production. Science
progress, 101(1), 52-75. https://doi.org/10.3184/003685018X15173975498947
Samie, A., Obi, C. L., Barrett, L., Powell, S., & Guerrant, R. J. J. o. I. (2007). Prevalence of
Campylobacter species, Helicobacter pylori and Arcobacter species in stool samples from
the Venda region, Limpopo, South Africa: studies using molecular diagnostic methods.
54(6), 558-566.
Samuel, M. C., Vugia, D. J., Shallow, S., Marcus, R., Segler, S., McGivern, T., Kassenborg, H.,
Reilly, K., Kennedy, M., & Angulo, F. J. C. I. D. (2004). Epidemiology of sporadic
Campylobacter infection in the United States and declining trend in incidence, FoodNet
1996–1999. 38(Supplement_3), S165-S174. https://doi.org/10.1086/381583
Sebald, M., & Veron, M. (1963). Base DNA content and classification of vibrios. Annales de
l'Institut Pasteur,
Sender, R., Fuchs, S., & Milo, R. J. P. b. (2016). Revised estimates for the number of human and
bacteria cells in the body. 14(8), e1002533.
Shang, Y., Kumar, S., Oakley, B., & Kim, W. K. (2018). Chicken Gut Microbiota: Importance and
Detection Technology [Review]. Frontiers in Veterinary Science, 5(254).
https://doi.org/10.3389/fvets.2018.00254
She, Y., Cai, H., & Liu, G. (2018). Effects of antibiotic on microflora in ileum and cecum for
broilers by 16S rRNA sequence analysis. Animal Science Journal, 89(12), 1680-1691.
https://doi.org/10.1111/asj.13113

37

Shen, Z., Wang, Y., Zhang, Q., Shen, J. J. A. R. i. B. f. L., & Animals, C. (2018). Antimicrobial
resistance in Campylobacter spp. 317-330.
Sheppard, S. K., Jolley, K. A., & Maiden, M. C. J. (2012). A gene-by-gene approach to bacterial
population genomics: whole genome MLST of Campylobacter. Genes, 3(2), 261-277.
Shreeve, J., Toszeghy, M., Pattison, M., & Newell, D. J. A. d. (2000). Sequential spread of
Campylobacter infection in a multipen broiler house. 983-988.
Silverman, M. S., Davis, I., & Pillai, D. R. (2010). Success of self-administered home fecal
transplantation for chronic Clostridium difficile infection. Clinical Gastroenterology and
Hepatology, 8(5), 471-473.
Skånseng, B., Kaldhusdal, M., & Rudi, K. (2006). Comparison of chicken gut colonisation by the
pathogens Campylobacter jejuni and Clostridium perfringens by real-time quantitative
PCR.
Molecular
and
Cellular
Probes,
20(5),
269-279.
https://doi.org/10.1016/j.mcp.2006.02.001
Smith, H. W., & Tucker, J. F. (1978). The effect of antimicrobial feed additives on the colonization
of the alimentary tract of chickens by Salmonella typhimurium. Journal of Hygiene, 80(2),
217-231. https://doi.org/10.1017/S0022172400053560
Snelling, W., Matsuda, M., Moore, J., & Dooley, J. J. L. i. a. m. (2005). Campylobacter jejuni.
41(4), 297-302.
Sun, X., Jia, Z. J. V. i., & immunopathology. (2018). Microbiome modulates intestinal homeostasis
against inflammatory diseases. 205, 97-105.
Sun, X., Winglee, K., Gharaibeh, R. Z., Gauthier, J., He, Z., Tripathi, P., Avram, D., Bruner, S.,
Fodor, A., & Jobin, C. (2018). Microbiota-Derived Metabolic Factors Reduce
Campylobacteriosis in Mice. Gastroenterology, 154(6), 1751-1763.e1752.
https://doi.org/https://doi.org/10.1053/j.gastro.2018.01.042
Tauxe, R. V. (1992). Epidemiology of Campylobacter jejuni infections in the United States and
other industrialized nations. Campylobacter jejuni: current status and future trends.
USDA, F. (2020). Livestock and Poultry: World Markets and Trade. United States Department of
Agriculture. Retrieved 12/21 from https://www.fas.usda.gov/data/livestock-and-poultryworld-markets-and-trade
Vaezirad, M. M., Keestra-Gounder, A. M., de Zoete, M. R., Koene, M. G., Wagenaar, J. A., & van
Putten, J. P. M. (2017). Invasive behavior of Campylobacter jejuni in immunosuppressed
chicken. Virulence, 8(3), 248-260. https://doi.org/10.1080/21505594.2016.1221559
van der Hooft, J. J. J., Alghefari, W., Watson, E., Everest, P., Morton, F. R., Burgess, K. E. V., &
Smith, D. G. E. (2018). Unexpected differential metabolic responses of Campylobacter
jejuni to the abundant presence of glutamate and fucose. Metabolomics, 14(11), 144.
https://doi.org/10.1007/s11306-018-1438-5
38

Van Deun, K., Pasmans, F., Ducatelle, R., Flahou, B., Vissenberg, K., Martel, A., Van den Broeck,
W., Van Immerseel, F., & Haesebrouck, F. (2008). Colonization strategy of Campylobacter
jejuni results in persistent infection of the chicken gut. Veterinary microbiology, 130(3-4),
285-297.
Vandamme, P., Vancanneyt, M., Pot, B., Mels, L., Hoste, B., Dewettinck, D., Vlaes, L., Van Den
Borre, C., Higgins, R., Hommez, J. J. I. J. o. S., & Microbiology, E. (1992). Polyphasic
taxonomic study of the emended genus Arcobacter with Arcobacter butzleri comb. nov.
and Arcobacter skirrowii sp. nov., an aerotolerant bacterium isolated from veterinary
specimens. 42(3), 344-356.
Vandeputte, J., Martel, A., Canessa, S., Van Rysselberghe, N., De Zutter, L., Heyndrickx, M.,
Haesebrouck, F., Pasmans, F., & Garmyn, A. (2019). Reducing Campylobacter jejuni
colonization in broiler chickens by in-feed supplementation with hyperimmune egg yolk
antibodies. Scientific Reports, 9(1), 8931. https://doi.org/10.1038/s41598-019-45380-z
Véron, M., & Chatelain, R. (1973). Taxonomic Study of the Genus Campylobacter Sebald and
Véron and Designation of the Neotype Strain for the Type Species, Campylobacter fetus
(Smith and Taylor) Sebald and Véron. International Journal of Systematic and
Evolutionary
Microbiology,
23(2),
122-134.
https://doi.org/https://doi.org/10.1099/00207713-23-2-122
Wang, J., Lang, T., Shen, J., Dai, J., Tian, L., & Wang, X. (2019). Core Gut Bacteria Analysis of
Healthy Mice [Original Research]. Frontiers in Microbiology, 10(887).
https://doi.org/10.3389/fmicb.2019.00887
Wei, S., Morrison, M., & Yu, Z. J. P. s. (2013). Bacterial census of poultry intestinal microbiome.
92(3), 671-683.
Whelan, M. V. X., Ardill, L., Koide, K., Nakajima, C., Suzuki, Y., Simpson, J. C., & Ó Cróinín,
T. (2019). Acquisition of fluoroquinolone resistance leads to increased biofilm formation
and pathogenicity in Campylobacter jejuni. Scientific Reports, 9(1), 18216.
https://doi.org/10.1038/s41598-019-54620-1
WHO. (2012). The evolving threat of antimicrobial resistance: Options for action. Retrieved
30/12// from http://whqlibdoc.who.int/publications/2012/9789241503181_eng.pdf
Wieczorek, K., & Osek, J. (2013). Antimicrobial Resistance Mechanisms amongCampylobacter.
BioMed Research International, 2013, 340605. https://doi.org/10.1155/2013/340605
Zacharof, M. P., & Lovitt, R. W. (2012). Bacteriocins Produced by Lactic Acid Bacteria a Review
Article. APCBEE Procedia, 2, 50-56. https://doi.org/10.1016/j.apcbee.2012.06.010

39

CHAPTER II
Microbiota from Specific Pathogen-Free Mice Reduces Campylobacter jejuni Chicken
Colonization
Ayidh Almansour1,2, and Xiaolun Sun1*
1

Department of Poultry Science, 2Cell and Molecular Biology (CEMB), University of Arkansas,
Fayetteville, AR 72701, USA
*Corresponding author:
Department of Poultry Science
College of Agricultural, Food and Life Sciences
University of Arkansas
Fayetteville, AR 72704.
Phone: (479) 575-2322
Email xiaoluns@uark.edu
This
manuscript
has
been
published
https://pubmed.ncbi.nlm.nih.gov/3483254

40

on

Pathogens,

27

October

2021

2.1

Abstract
Campylobacter jejuni, a prevalent foodborne bacterial pathogen, is mainly transmitted

from poultry with few effective prevention approaches. In this study, we aimed to investigate the
role of microbiota on C. jejuni chicken colonization. Microbiota from specific pathogen-free (SPF)
mouse stools were collected as SPF-Aerobe and SPF-Anaerobe. Birds were colonized with SPFAerobe or SPF-Anaerobe at day 0 and infected with C. jejuni AR101 at day 12. Notably, C. jejuni
AR101colonized at 5.3 and 5.6 log10 C. jejuni CFU/g chicken cecal digesta at days 21 and 28,
respectively, while both SPF-Aerobe and SPF-Anaerobe microbiota reduced pathogen
colonization. Notably, SPF-Aerobe and SPF-Anaerobe increased cecal phylum Bacteroidetes and
reduced phylum Firmicutes compared to those in the non-transplanted birds. Interestingly,
microbiota from noninfected chickens, SPF-Aerobe, or SPF-Anaerobe inhibited AR101 in vitro
growth, whereas microbiota from infected birds alone failed to reduce pathogen growth. The
bacterium Enterobacter102 isolated from infected birds transplanted with SPF-Aerobe inhibited
AR101 in vitro growth and reduced pathogen gut colonization in chickens. Together, SPF mouse
microbiota was able to colonize chicken gut and reduce C. jejuni chicken colonization. The
findings may help the development of effective strategies to reduce C. jejuni chicken
contamination and campylobacteriosis.

Keywords: microbiota transplantation; foodborne pathogen; intestine; bacterial
colonization; specific pathogen-free.
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2.2

Background
Campylobacter jejuni colonizes asymptomatically in the intestinal tract of poultry and

causes a prevalent foodborne campylobacteriosis around the world [1,2]. C. jejuni resistant to
macrolides, fluoroquinolones, aminoglycosides, or carbapenems has been detected in samples
from children and adults worldwide [1–7]. More than 20 cases of campylobacteriosis per 100,000
population were reported in the USA in 2019 [8], and more than 220,000 people were affected in
Europe in 2019 [9]. The case number was more than the total incidences induced by eight other
bacterial pathogens [10]. More than 14.35 cases per 0.1 million people were caused by the
pathogen in 2020 [11]. Moreover, C. jejuni often causes severe post-infectious complications, such
as arthritis [12], the neurodegenerative disorder Guillain–Barr syndrome [13], irritable bowel
syndrome [14], and inflammatory bowel diseases (IBD) [15,16].To reduce campylobacteriosis,
different measures have been implemented to reduce enteritis by reducing C. jejuni contamination
in animal food, particularly pre- and post-harvest poultry. The intervention methods include strict
biosecurity on farms [17], vaccines [18], probiotics [19], phages [20], decontamination of poultry
carcasses in the post-slaughter process [21], facility design and management, reducing
contamination in feed, transportation, and other sources, and other strategies [2]. It is estimated
that decreasing Campylobacter count on chicken carcasses by 100 times decreases human
campylobacteriosis 30-fold [22]. Although those reduction measurements reduce some C. jejuni
contamination, improved and alternative strategies are much needed, as reflected in the consistent
high level of campylobacteriosis incidence reported in the Morbidity and Mortality Weekly Report
from the Infectious Disease Database at CDC between 1996 and 2017 [23].
The gastrointestinal tract of humans and animals is inhabited by trillions of microbes, collectively
called the microbiota [24,25]. The gut microbiota modulates essential host physiology and various
host functions such as the intestinal barrier, nutrition, and immune homeostasis [25–29]. Specific
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pathogen-free (SPF) Il10-/- mice are naturally resistant to C. jejuni 81–176-induced colitis, while
the mice become susceptible to campylobacteriosis after being treated with the broad-spectrum
antibiotic clindamycin [30]. Sequencing and bioinformatic analysis of 16S rDNA revealed that
microbiota-mediated bile acid metabolism was essential for preventing C. jejuni-induced colitis.
Increasing evidence is emerging on gut microbiota preventing C. jejuni colonization in poultry
[31–33]. Apart from naturally transmitting microbiota from wild hens to turkey chicks, the turkey
microbiota transmission is disrupted in modern industrialized poultry production, partly because
eggs are hatched by a hatchery instead of hens [34]. Poultry chicks obtain their microbiota from
the environment and/or farms, where most of the microbes are not natural inhabitants of the bird
gut [35]. The application of antibiotics as growth promoters further drives the dysbiosis of birds
in commercial poultry production [36]. In our previous studies, we found that transplanting bile
acid deoxycholic acid-modulated microbiota to hatched chicks reduced the colonization of C.
jejuni human clinical isolate 81–176 and chicken isolate AR101 in pre-harvest chickens [37].
Because SPF mice are naturally resistant against a C. jejuni infection [30,38], in this study,
we hypothesized that SPF mouse microbiota would be able to colonize chickens and reduce C.
jejuni chicken colonization. Our data indicate that the mouse SPF-Aerobe and SPF-Anaerobe
microbiota shaped the chicken intestinal microbiota. Furthermore, the SPF-Aerobe and SPFAnaerobe indeed reduced C. jejuni AR101 in vitro growth and chicken colonization. These
findings will help the development of effective strategies against C. jejuni chicken colonization.
2.3

Materials and methods

2.3.1 Mouse microbiota preparation and
transplantation and C. jejuni infection

chicken

experiments

of

microbiota

The performed animal experiments were in accordance with the Animal Research:
Reporting of In Vivo Experiments (https://www.nc3rs.org.uk/arrive-guidelines accessed on 22
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August 2019) and approved by the Institutional Animal Care and Use Committee of the University
of Arkansas (protocols No. 20009 for mice and 20011 for chickens). For the bird experiment with
SPF microbiota, a total of 135 zero-day-old Cobb 500 broiler chicks were randomly allocated into
cohorts of 15–30 birds per group, as detailed in Supplementary Table S1. The birds obtained from
Cobb-Vantress (Siloam Springs, AR, USA) were neck-tagged and randomly assigned to floor pens
with a controlled age-appropriate environment. The birds were fed a corn-soybean meal-based
starter diet during days 0–10 and a grower diet during days 11–28. The basal diet was formulated
as described earlier [37,52]. Stool from eight-week-old SPF BL6 Il10−/− mice fed a chew diet was
freshly collected and immediately suspended in 30% glycerol PBS stock and stored at −80 °C. The
stool samples were cultured on brain heart infusion (BHI, BD Biosciences, Franklin Lakes, NJ,
USA) agar plates at 42 °C for 48 h under aerobic or anaerobic conditions using the GasPak system
(BD Biosciences, Franklin Lakes, NJ, USA) and collected as SPF-Aerobe and SPF-Anaerobe
microbiota. The microbiota was added glycerol at final 30% and stored at −80 °C. Before the
chicken colonization experiment, the SPF-Aerobe and SPF-Anaerobe microbiota were cultured on
a BHI plate for 48 h, collected in PBS, and enumerated by OD600 and plating. OD600 of 1 was
estimated at about 108 CFU/mL. At chicken experiments, chicks at day 0 were orally gavaged once
with PBS or 108 CFU/bird SPF-Aerobe or 108 CFU/bird SPF-Anaerobe. For the chicken
experiment of Enterobacter102, a total of 90 zero-day-old Cobb 500 broiler chicks were randomly
allocated into cohorts of 30 birds per group. The birds were fed and raised similarly to those in the
SPF microbiota experiment. The chickens were orally gavaged once with PBS or 108 CFU/bird
of Enterobacter102 in 0.5 mL/bird on day 0. Two days before infection, frozen stock of C.
jejuni AR101 (isolated at Dr. Billy Hargis’s lab at University of Arkansas at Fayetteville) were
cultured microaerobically at 42 °C for 48 h on C. jejuni-selective blood plates. The motility of C.

44

jejuni was ensured under a microscope as described before [53] and routinely examined on
semisolid MH (0.4% agar) plates. C. jejuni AR101 in PBS was estimated as that OD600 of 0.468
was 1010 CFU/mL. The bacterium was also serially diluted, cultured on the Campylobacterselective plates, and enumerated 48 h later. The Campylobacter-selective plate was prepared inhouse and it consisted of Bolton’s Campylobacter Enrichment (CE) Broth (Neogen Food Safety,
Lasing, MI, USA), 1.5% agar (VWR, USA, OH), 5% lysed horse blood (VWR, Radner Township,
PA, USA), five antibiotics (20 mg/L cefoperazone, 50 mg/L cycloheximide, 20 gm/L
trimethoprim, 20 mg/L vancomycin, and 0.35 mg/L polymyxin B), 500 mg/L ferrous sulfate, and
200 mg/L triphenyl-tetrazolium chloride (TTC) (all from Sigma-Aldrich, St. Louis, MO, USA).
The ferrous sulfate and TTC were used to make C. jejuni colonies dark red. The birds were
gavaged with 1 mL PBS or 109 CFU/bird C. jejuni AR101 at day 12 [37]. Chicken body weight
was measured at days 0 and 28. Because of the pen size constrains, the birds were randomly
euthanized at days 21 and 28 to collect cecal samples for enumerating C. jejuni, and the exact bird
numbers are listed in figure legends.
This experiment was conducted until 28 days of age because of the pen size constrain.
Cecal digesta samples of all the groups were collected for DNA isolation. Another set of cecal
digesta were serially diluted ten-fold with sterile PBS and cultured on the Campylobacter-selective
plates at 42 °C for 48 h under a microaerophilic atmosphere. Emerged colonies were positively
determined as C. jejuni only when they were dark red and shining, round, and with a smooth
surface. The colonies were also examined under a microscope for size and motility evaluation [53].
The CFU per gram digesta was then calculated.
2.3.2 Estimation of microbiota composition at phylum level
Cecal digesta samples were collected, and DNA was extracted using bead beater disruption
and phenol: chloroform separation method as described before [54]. Briefly, 0.1 g of fecal sample
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suspended in 500 μL PBS was transferred to a 2 mL screw cap tube containing 85 μL of 10% SDS
solution, 500 μL of phenol/chloroform (25:24), and 0.3 g sterile 0.1 mm zirconia beads (BioSpec,
Bartlesville, OK, USA). The samples were homogenized on a Fisher brand Bead Mill 24
Homogenizer (Fisher Scientific, Pittsburg, PA, USA) for 3 × 30 s at high speed with a 10 s pause
for each run. After centrifugation, the supernatant was further extracted twice with 500 μL of
chloroform (25:24), and the top aqueous layer was collected and mixed with 1/10 Vol (~50 μL)
3M sodium acetate (pH 5.2) and 2.5 Vol (~1.25 mL) ethanol overnight at –20 °C. After
centrifugation, the DNA pellet was washed once with 70% ethanol and resuspended in 100 μL
DNase/RNase-free H2O. The abundance levels of five phyla of gut bacteria were determined by
real-time PCR according to the manufacturer’s recommendation. Briefly, each PCR reaction
mixture comprised 4 μL of BioRad iTaq Universal SYBER Green Super mix (BioRad, Hercules,
CA, USA), 1.6 μL of template DNA (~4 ng), 0.6 μL of 5 μM primer mix, and 1.8 μL of
DNase/RNase H2O. The amplification reaction was performed in a BioRad 384 Real-Time PCR
machine (BioRad, Hercules, CA, USA) using the following program: 1 min at 95 °C, followed by
30 cycles of 30 s each at 95 °C, 60 s at 60 °C. The gene primers [37] used included universal 16S
rRNA:

16S357F

5′-CTCCTACGGGGAGGCAGCAA-3′,

ACGGGCGGTGTGTRC-3′; α-Proteobacteria:
908αR

α682F

γ1202R

5′-

5′-CIAGTGTAGAGGTGAAATT-3′,

5′-CCCCGTCAATTCCTTTGAGTT-3′; γ-Proteobacteria:

TCGTCAGCTCGTGTYGTGA-3′,

16S1392R

1080γF

5′-

5′-CGTAAGGGCCATGATG-3′; Bacteroidetes:

798cfbF 5′-CRAACAGGATTAGATACCCT-3′,cfb967R 5′-GGTAAGGTTCCTCGCGTAT3′; Firmicutes:

928FirmF

5′-TGAAACTYAAAGGAATTGACG-3′,

ACCATGCACCACCTGTC-3′; Actinobacteria:

Act920F3

1040FirmR

5′-

5′-TACGGCCGCAAGGCTA-3′,

Act1200R 5′-TCRTCCCCACCTTCCTCCG-3′. The relative percentage of each phylum was
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calculated following the relative PCR quantification method [55] similar to that in this paper [55].
Briefly, the 2−ΔΔCT value of each phylum gene expression Ct in one sample was calculated using
the universal 16S rRNA gene expression Ct. The percentage of each phylum was then calculated
by the phylum 2−ΔΔCT value in one sample divided by the sum of all phylum 2−ΔΔCT values in the
same sample and multiplied by 100.
2.3.3 Isolation of Enterobacter102
When chicken cecal digesta were cultured on C. jejuni selective plates, pink colonies were
grown on the plate, compared to dark red C. jejuni colonies. The pink colony was
named Enterobacter102. Under a light microscope, Enterobacter102 was rod-shaped and larger
than C. jejuni. Enterobacter102 was able to grow aerobically, stained Gram-negative, and showed
pink colonies on a MacConkey plate.
2.3.4 Identification of bacterial species using 16s DNA and sanger sequencing
Either C. jejuni AR101 or Enterobacter102 was derived from a single colony. To isolate
DNA for Sanger sequencing, the bacteria were spread on the respective agar plates. The bacteria
were collected, and DNA was extracted. Genomic DNA from C. jejuni AR101 or Enterobacter102
was amplified by PCR of the 16S rDNA gene region with universal primers (27Fw1: 5′AGAGTTTGATCMTGGCTCAG-3′, 1492R: 5′- CGGTTACCTTGTTACGACTT-3′) following
the instructions in this webpage https://chmi-sops.github.io/mydoc_16S_Sanger.html (accessed
on 20 July 2020). The PCR products were gel-purified and Sanger-sequenced at Eurofins Scientific
using

primers

of

27Fw1,

1492R,

and

universal

primer

515Fw2:

5′-

GTGCCAGCMGCCGCGGTAA-3′. The sequences were assembled and aligned using the NCBI
genome database. The bacteria were given species names with >98.0% and 95.0% of 16S rDNA
sequence homology for Campylobacter jejuni and Enterobacter sp., respectively. The 16s rDNA
sequences were uploaded at NCBI with submission numbers of SUB10285129 and SUB10285090.
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2.3.5

In Vitro co-culture of C. jejuni with various microbiota
The impact of various microbiota on C. jejuni growth was evaluated. Briefly, C.

jejuni AR101 from frozen stocks was cultured and grown on the Campylobacter-selective plates
in a microaerophilic atmosphere for 48 h using the GasPak system (BD Biosciences, Franklin
Lakes, NJ, USA). C. jejuni at 6.3×108 CFU was co-cultured with noninfected microbiota at 2.0 ×
108 CFU, SPF-Aerobe at 1.8×108 CFU, or SPF-Anaerobe at 8.4 × 108 CFU in 1 mL of CE broth. C.
jejuni at 7.7×108 CFU was co-cultured with Cj-MB at 6.7 × 107 CFU, Cj-SPF-Aerobe at
1.6×109 CFU, or Cj-SPF-Anaerobe at 1.5×109 CFU in 1 mL of CE broth. C. jejuni at 1.8×108 CFU
and 4.4×107 CFU Enterobacter102 were co-cultured in 1 mL of CE broth. The experiments were
carried out in triplicate. Because C. jejuni growth would be reduced within 24 h in anaerobic
conditions [54], the co-culture bacteria were incubated for 24 h at 42 °C under anaerobic conditions
using the GasPak system (BD Biosciences, Franklin Lakes, NJ, USA) to mimic cecal air
conditions. C. jejuni growth was measured by serial dilution and plating on the Campylobacterselective plates for enumeration. When co-culture with C. jejuni, Enterobacter102 was counted
with pink colonies compared to dark red colonies of C. jejuni. Cj-MB, Cj-SPF-Aerobe, and CjSPF-Anaerobe themselves could not grow a single colony on the Campylobacter-selective plates,
suggesting that C. jejuni lost culturability after storing with microbiota.
2.3.6 Statistical analysis
All values are shown as mean ± standard error of the mean as indicated. Differences
between groups were analyzed using the nonparametric Mann–Whitney U test performed using
GraphPad Prism 7.0 software. C. jejuni CFU was transformed with a formula of log10 (CFU + 1).
The results were considered statistically significant if p-values were <0.05.
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2.4
2.4.1

Results
Mouse microbiota reduced C. jejuni AR101 chicken colonization
Mouse SPF-Aerobe and SPF-Anaerobe microbiota was prepared from SPF mouse stools

and transplanted to zero-day-old chicks. DNA from C. jejuni chicken isolate AR101 was isolated,
and 16S rDNA was PCR-amplified, Sanger-sequenced, and confirmed to be in 99.0% alignment
with C. jejuni. The birds were infected with AR101 at day 12. Consistently with our previous
reports [37], C. jejuni was not detected in noninfected birds, suggesting clean housing at our
poultry facility. Notably, mouse SPF-Aerobe and SPF-Anaerobe microbiota reduced C.
jejuni AR101 cecal colonization by more than 1-log compared to that of only infected birds (Cj
AR101) at day 21 (3.8 ± 0.2 and 4.1 ± 0.0 vs. 5.3 ± 0.4 log10 C. jejuni CFU/g cecal digesta,
respectively) (Figure 1A). The SPF-Aerobe and SPF-Anaerobe continued to reduce C.
jejuni chicken colonization compared to that of the infected control birds at day 28 (4.0 ± 0.6 and
4.9 ± 0.1 vs. 5.6 ± 0.2 log10 C. jejuni CFU/g cecal digesta, respectively) (Figure 1B). Notably, the
SPF-Anaerobe microbiota with or without C. jejuni AR101 infection increased the accumulative
body weight compared to that of noninfected birds from day 0 to day 28 (1606 ± 17.7 and 1683 ±
43.1 vs. 1463 ± 47.6 g/bird, respectively) (Figure S1), while SPF-Aerobe microbiota did not
increase the bird weight gain. These results suggest that SPF-Aerobe and SPF-Anaerobe
effectively reduce C. jejuni AR 101 colonization in the chicken.
2.4.2

SPF-Aerobe and SPF-Anaerobe modulated the chicken microbiota
We reasoned that the colonization reduction of AR101 in chickens might come from

chicken microbiota alteration by the mouse microbiota transplantation. To assess this hypothesis,
we used phylum-specific primers to analyze the microbiota composition change. Notably, SPFAerobe and SPF-Anaerobe reduced the relative abundance of the phylum Firmicutes compared to
that of uninfected birds (61.3 and 52.9 vs. 97.5%) and infected birds (51.9 and 50.9 vs. 86.7%,
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respectively), while the relative abundance of Bacteroidetes was increased compared to that of
uninfected birds (38.4 and 44.7 vs. 2.3%) and infected birds (42.0 and 47.6 vs. 12.4%, respectively)
(Figure 2). Interestingly, C. jejuni colonization modulated chicken cecal microbiota of the
phyla Bacteroidetes and Firmicutes. Importantly, most of the relative abundance was significant
(Table 1). These results indicate that SPF-Aerobe, SPF-Anaerobe, and C. jejuni were able to
colonize and change the microbiota in the chicken gut.
2.4.3

Chicken noninfected microbiota and mouse SPF microbiota reduced C. jejuni growth
Upon validation of transplanted mouse SPF microbiota reducing C. jejuni chicken

colonization, we reasoned that the mouse SPF microbiota would directly inhibit C. jejuni AR101
growth, while the chicken microbiota would not. To examine this hypothesis, C. jejuni AR101
inoculum was co-cultured with microbiota from noninfected, SPF-Aerobe, and SPF-Anaerobe
chickens in the Campylobacter Enrichment (CE) Broth at 42 °C for 24 h under anaerobic
conditions. Notably, both SPF-Aerobe and SPF-Anaerobe reduced C. jejuni AR101 by more than
1-log compared to the C. jejuni AR101 culture-alone group (6.8 ± 0.2 and 6.3 ± 0.1 vs. 8.6 ± 0.3
log10 C. jejuni CFU/mL, respectively) (Figure 3). Interestingly, the microbiota from noninfected
chickens also reduced C. jejuni AR101 growth by more than 2-log compared to that in the C.
jejuni AR101 culture alone (6.4 ± 0.4 vs. 8.6 ± 0.3 log10 C. jejuni CFU/mL, respectively). Notably,
each microbiota at 24 h increased the number of CFU compared to that at 0 h (Figure S2). Because
of the unexpected result of noninfected chicken microbiota reducing C. jejuni AR 101 in vitro
growth, we then modulated our hypothesis that C. jejuni possibly modulated chicken microbiota
for its growth and colonization. To address this reasoning, we co-cultured C. jejuni AR101 with
chicken microbiota from only infected birds (Cj-MB), transplanted with SPF-Aerobe and infected
birds (Cj-SPF-Aerobe), and transplanted with SPF-Anaerobe and infected birds (Cj-SPFAnaerobe). Interestingly, the three-chicken microbiota themselves could not grow a single colony
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on the Campylobacter-selective plates (Figure 4), suggesting that C. jejuni lost culturability after
storing with microbiota. Notably, Cj-MB did not reduce C. jejuni AR101 in vitro growth compared
to that in positive control of Cj AR101 culture alone. Consistently, Cj-SPF-Aerobe and Cj-SPFAnaerobe reduced C. jejuni AR101 in vitro growth by more than 3-log compared to that in the Cj
AR101 culture-alone group (3.7 ± 0.6 and 0.8 ± 0.5 vs. 7.3 ± 0.1 log10 C. jejuni CFU/mL,
respectively). Consistently, each microbiota at 24 h increased number of CFU compared to that at
0 h (Figure S3). These results suggest that C. jejuni modulated the chicken microbiota for its
growth and colonization, while the transplanted mouse SPF microbiota resisted against pathogen
growth.
2.4.4

An Aerobic bacterial isolate reduced C. jejuni AR101 In Vitro
Next, we wanted to identify and isolate the individual bacteria from the protective SPF

microbiota. About 100 bacterial colonies were isolated using BHI plates at 42 °C under anaerobic
conditions for 48 h. The colonies were individually co-cultured with C. jejuni for 24 h, and then C.
jejuni was enumerated on the Campylobacter-selective plates prepared in-house. Unfortunately,
none of the bacteria were able to inhibit C. jejuni growth using the co-culture method. By accident,
during one chicken trial, a bacterial colony from birds gavaged with mouse SPF-Aerobe was able
to grow with pink color on the Campylobacter-selective plate compared to the dark red color of C.
jejuni. The bacterial colony was selected and later named Enterobacter102. We reasoned that this
bacterium might resist C. jejuni infection. Enterobacter102 was rod-shaped, stained Gramnegative, and had the same size as E. coli. Enterobacter102 also grew in pink colonies on a
MacConkey agar plate. The DNA from Enterobacter102 was isolated, and 16S rDNA was PCRamplified, Sanger-sequenced, and confirmed to be in 95% alignment with Enterobacter sp. To
functionally dissect the interaction between Enterobacter102 and C. jejuni AR101, in vitro coculture was performed. Interestingly, Enterobacter102 showed the ability to reduce C.
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jejuni AR101 colonization by more that 2-log compared to that in the Cj AR101 culture-alone
group (4.6 ± 0.1 vs. 7.3 ± 0.1 log10 C. jejuni CFU/mL) (Figure 5). Not surprisingly, the number
of Enterobacter102 increased at 24 h compared to that at 0 h (Figure S4). Although the reduced C.
jejuni could result from depleted nutrients in the presence of a microbiota (SPF microbiota
or Enterobacter102), the comparable growth between Cj AR101 and Cj-MB AR101 in Figure
4 suggested that the microbiota was an important factor influencing C. jejuni growth. These results
suggested that Enterobacter102 has potential to reduce C. jejuni AR101 chicken colonization.
2.4.5

Enterobacter102 reduced C. jejuni AR101 chicken colonization
Encouraged by the result of Enterobacter102 reducing C. jejuni AR101 in vitro growth,

we then performed chicken experiments. The birds were colonized with 108 CFU/chick
of Enterobacter102 at day 0, infected with C. jejuni at day 12, and euthanized at days 21 and 28.
Consistently with the in vitro experiments, Enterobacter102 reduced C. jejuni AR101 chicken
colonization by more than 1-log at day 21 in comparison to that in only infected birds of the Cj
AR101 group (4.0 ± 0.0 vs. 5.3 ± 0.4 log10 C. jejuni CFU/g cecal digesta) (Figure 6A).
Notably, Enterobacter102 continued to reduce C. jejuni AR101 chicken colonization by more than
2-log at day 28 (2.4 ± 0.9 vs. 5.7 ± 0.2 log10 C. jejuni CFU/g cecal digesta) (Figure 6B). These
results suggest that the bacterial isolate of Enterobacter102 inhibited C. jejuni AR101 growth and
reduced the pathogen’s chicken colonization.
2.5

Discussion
Poultry is the main reservoir of the prevalent foodborne bacterial pathogen C. jejuni which

asymptomatically colonizes the birds [39]. However, the pathogen fails to colonize SPF or
conventionally raised mice [30,38]. We then hypothesized that the microbiota from SPF mice
might resist against C. jejuni infection, while the chicken microbiota might be susceptible to the
pathogen. Here we report that mouse SPF-Aerobe and SPF-Anaero microbiota reduced C.
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jejuni chicken colonization at days 21 and 28. Notably, SPF-Aerobe and SPF-Anaerobe increased
chicken cecal phylum Bacteroidetes and reduced phylum Firmicutes compared to those in the
infected-alone birds. Interestingly, the uninfected chicken microbiota, SPF-Aerobe, or SPFAnaerobe inhibited AR101 in vitro growth. Microbiota from birds transplanted with SPF-Aerobe
or SPF-Anaerobe and infected inhibited AR101 in vitro growth, whereas microbiota from C.
jejuni-infected-alone birds did not. Enterobacter102 isolated from infected birds transplanted with
SPF-Aerobe reduced AR101 in vitro growth and chicken colonization. Altogether, these findings
revealed that mouse SPF microbiota is able to colonize the chicken gut and resists against C.
jejuni colonization in chickens, suggesting a potential strategy to reduce C. jejuni chicken
contamination.
A notable observation from this study is that the mouse microbiota was able to be successfully
transplanted into chickens and to reduce C. jejuni chicken colonization. It is a well-known medical
practice to transplant a healthy donor’s microbiota to treat a human Clostridium
perfringens infection [40]. The microbiota compositions of human recipients are comparable to
those of the human donor’s, and the C. difficile infection is reduced. Consistently, microbiota
composition in recipient piglets is similar to that of human donors in an inter-mammalian
microbiota transplantation [41], suggesting that it is feasible to transplant microbiota between
animals within the class level of Mammalia. In the current study, we successfully transplanted
mouse (class Mammalia) microbiota to chickens (class Aves), suggesting it is possible to
transplant microbiota between animals within the phylum level of Chordata. Apparently, the
difference of body temperature (42 °C in chickens and 37 °C in mice) and intestinal anatomy
between the animals did not reduce the donor mouse microbiota colonization in the recipient
chickens. A meta-data analysis study showed that chicken microbiota at the phylum level is mainly
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comprised

of

13

phyla,

including

Firmicutes (70.0%), Bacteroidetes (12.3%), Proteobacteria (9.3%), and other small proportions
of Actinobacteria, Cyanobacteria, Spirochaetes,

Synergisteles,

Fusobacteria, Tenericute,

and Verrucomicrobia [42]. Consistent with this finding, we found that birds without a mouse
microbiota transplantation had the phylum Firmicutes majority, while microbiota-transplanted
birds

dramatically

reduced Firmicutes and

increased Bacteroidetes,

independently

of C.

jejuni infection. Interestingly, the microbiota in mice is composed of the phyla Firmicutes at 54%
and Bacteroidetes at 30% [43], which is close to the composition of our transplanted chicken
microbiota. A field survey study reported that birds from the farms with the
highest Campylobacter counts show the highest percentage of Firmicutes and the lowest
percentage of Bacteroidetes in their microbiota, although microbiota composition is highly
variable between or within farms [44]. In addition, the significant reduction of C.
jejuni colonization by SPF-Aerobe and SPF-Anaerobe microbiota in both days 21 and 28
suggested that the microbiota may continue to reduce pathogen colonization for a longer period of
time. This experiment was cut short because of the pen size constrain. It would be interesting in
the future to conduct follow-up experiments to reduce C. jejuni colonization by SPF microbiota
for birds at the market age of days 35–45. Together, these data showed that mouse SPF microbiota
is transplantable to reduce C. jejuni chicken colonization.
After the evaluation of the protective effect of the mouse SPF microbiota, it is imperative to
isolate and identify individual bacteria in the microbiota against C. jejuni chicken colonization for
further functional evaluation. In a human longevity study, Sato and colleagues have plate-cultured,
isolated, and evaluated a group of 68 bile acid metabolizing bacteria [45]. They found
that Parabacteroides merdae and Odoribacteraceae strains produced isoalloLCA and reduced
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Gram-positive

multidrug-resistant

pathogens,

such

as C.

difficile and

vancomycin-

resistant Enterococcus faecium [45]. A microbiota with higher level of genera Clostridium
XI, Bifidobacterium, and Lactobacillus is associated with resistance to C. jejuni-induced colitis in
mice [30]. Interestingly, probiotics Bifidobacterium longum PCB133 and a xylo-oligosaccharide
do not decrease C. jejuni chicken colonization [46]. We have co-cultured C. jejuni with various
ATCC or lab-isolated bacteria, such as Bifidobacterium longum and Clostridium scindens, and we
did not find the bacteria to reduce C. jejuni in vitro growth (data not shown). During our search
for individual microbiota against C. jejuni, we found that the Enterobacter102 from microbiota of
SPF-Aerobe grew as pink colonies on the Campylobacter-selective plates. Later, we found
that Enterobacter102 reduced C. jejuni in vitro growth and chicken colonization. Probiotic
application of Enterobacter sp. improves both Mediterranean fruit fly (medfly) pupal and adult
productivity and reduces rearing duration [47]. Most other reports showed that Enterobacter sp. is
a pathogen and induces intestinal inflammation [48,49]. Future research on how Enterobacter102
reduces C. jejuni growth and chicken colonization is much needed. We are working on
identifying Enterobacter102 and other bacterial candidates by culture-isolation and 16S rDNA
Sanger sequencing. Together, these data suggest that individual bacteria in the SPF microbiota
might be able to be isolated and used to reduce C. jejuni growth and chicken colonization.
Another interesting finding from the current study is that the microbiota from noninfected
birds at day 28 was able to reduce C. jejuni in vitro growth, while microbiota from infected-alone
birds failed to reduce pathogen growth. The results suggest that C. jejuni might have modulated
the chicken microbiota for facilitating pathogen colonizing and thriving in the gut. It is a consensus
that intestinal microbiota influences C. jejuni colonization and induction of enteritis [24,50], as
also discussed in the paragraphs above. However, few reports showed that C. jejuni modulates the
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microbiota to benefit its own colonization. Salmonella Enteritidis infection reduces the overall
diversity of the chicken microbiota population with an expansion of the Enterobacteriaceae family
for promoting pathogen colonization [51]. In the current study, we found that a C. jejuni infection
increased the phylum Bacteroidetes compared to that in noninfected birds. Future research is
needed to identify which specific bacteria are increased to facilitate C. jejuni colonization.
In conclusion, the mouse SPF microbiota was able to colonize chicken ceca and reduced C.
jejuni chicken colonization. The reduction of C. jejuni chicken colonization might come from
reduced bacteria in the phylum Firmicutes and/or increased bacteria in the phylum Bacteroidetes.
Notably, Enterobacter102 reduced C. jejuni in vitro growth and chicken colonization. Altogether,
these findings provide a feasible strategy to reduce C. jejuni chicken contamination and human
campylobacteriosis.
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Table 2.1
Group A

Significant p-values of relative abundance at the phylum level between groups
Compared to group B
SPF-Aerobe

Noninfected

SPF-Anaerobe
Cj AR101
SPF-Aerobe+Cj AR101

Cj AR101
SPF-Anaerobe+Cj AR101
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Phylum
Bacteroidetes
Firmicutes
Bacteroidetes
Firmicutes
Bacteroidetes
Firmicutes
Bacteroidetes
Firmicutes
Bacteroidetes
Firmicutes

p-value
< 0.001
< 0.001
< 0.001
< 0.001
0.02
0.04
< 0.001
< 0.001
< 0.001
< 0.001

Figure 2.1

Murine microbiota reduced C. jejuni AR101 chicken colonization

Zero-day-old broiler chickens precolonized with SPF-Aerobe and SPF-Anaerobe were infected
with C. jejuni AR101 at 12 days of age. The birds were euthanized at days 21 and 28. The bird
cecal digesta was collected, serially diluted, and cultured on Campylobacter-selective agar plates
prepared in-house at 42 °C under microaerobic atmosphere. (A) C. jejuni chicken colonization in
the ceca of the birds at day 21. The bird number for each group was: noninfected (n = 10), Cj
AR101 (n = 10), SPF-Aerobe (n = 5), and SPF-Anaerobe (n = 10). (B) C. jejuni chicken
colonization in the ceca of the birds at day 28. The bird number for each group was: noninfected
(n = 20), Cj AR101 (n = 20), SPF-Aerobe (n = 10), and SPF-Anaerobe (n = 20). All graphs depict
the mean + SEM. Significant if p < 0.05. The results are representative of three independent
experiments.
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Figure 2.2

SPF microbiota modified the chicken microbiota at day 28

The birds were colonized with microbiota and infected with C. jejuni AR101 at day 12 as in Figure
1. Cecal digesta was collected at day 28, and DNA was extracted. Real-time PCR was per-formed
to calculate bacterial composition at the phylum level. The detailed p-values were listed in Table
2.1. The results are representative of three independent experiments.
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Figure 2.3

In vitro co-culture of noninfected chicken microbiota and C. jejuni AR101

AR101 was co-cultured for 24 h with microbiota from noninfected, SPF-Aerobe, or SPF-Anaerobe
birds in vitro. AR101 growth was quantified by serially diluting and plating on the Campylobacter
selective agar plates. All graphs depict the mean + SEM. Significant if p < 0.05. The results are
representative of three independent experiments.
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Figure 2.4

In vitro co-culture of C. jejuni-modulated microbiota and C. jejuni AR101

C. jejuni AR101 was co-cultured with microbiota from infected-alone birds (Cj-MB), transplanted
with SPF-Aerobe and infected birds (Cj-SPF-Aerobe), and transplanted with SPF-Anaerobe and
infected birds (Cj-SPF-Anaerobe). AR101 growth was quantified by serially diluting and plating
on the Campylobacter-selective agar plates. All graphs depict the mean + SEM. Significant if p <
0.05. The results are representative of three independent experiments.
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Figure 2.5

In vitro co-culture of Enterobacter102 and C. jejuni AR101

C. jejuni AR101 was co-cultured with Enterobacter102. AR101 growth was quantified by serially
diluting and plating on Campylobacter-selective agar plates. All graphs depict the mean + SEM.
Significant if p < 0.05. The results are representative of three independent experiments.

68

Figure 2.6

Enterobacter102-modulated C. jejuni AR101 chicken colonization

Zero-day-old broiler chicks were precolonized with Enterobacter102 and infected with C. jejuni
AR101 at day 12. The birds were euthanized at days 21 and 28. The bird cecal digesta were
collected, serially diluted, and cultured on Campylobacter-selective agar plates under a
microaerobic atmosphere at 42 °C. (A) C. jejuni chicken colonization in the ceca of the birds at
day 21. The bird number for each group was: noninfected (n = 10), Cj AR101 (n = 10),
Enterobacter102 + Cj AR101 (n = 10). (B) C. jejuni chicken colonization in the ceca of the birds
at day 28. The bird number for each group was: noninfected (n = 20), Cj AR101 (n = 20),
Enterobacter102 + Cj AR101 (n = 20). All graphs depict the mean + SEM. Significant if p < 0.05.
The results are representative of three independent experiments.
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Table S2.1

Number of birds in each group of SPF microbiota experiments

Group

Pens/group

Number of birds/group

Noninfected

2

30

SPF-Anaerobe

2

30

Cj AR101

2

30

SPF-Aerobe+ Cj AR101

1

15

SPF-Anaerobe+ Cj AR102

2

30
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Figure S2.1

Accumulative body weight gain during d 0-28

Cohorts of chicks were colonized with mouse SPF microbiota and infected as in Figure 1. The bird
weight was measured at d 0 and 28. The bird number was same as d 28 in Figure 1. Showed were
accumulative body weight gain during d 0-28. All graphs depict mean + SEM. Significant if p
<0.05. Results are representative of 3 independent experiments.
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Figure S2.2

SPF-Microbiota growth co-cultured with C. jejuni for 24 hr

SPF microbiota was co-cultured with C. jejuni for 24 hr as described in Figure 3. Microbiota
growth was quantified by serially diluting and plating on BHI plates. All graphs depict mean +
SEM. Significant if p <0.05. Results are representative of 3 independent experiments
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Figure S2.3

Cj-SPF-Microbiota growth co-cultured with C. jejuni for 24 hr

Cj-SPF microbiota was co-cultured with C. jejuni for 24 hr as described in Figure 4. Microbiota
growth was quantified by serially diluting and plating on BHI plates. All graphs depict mean +
SEM. Significant if p <0.05. Results are representative of 3 independent experiments
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Figure S2.4

Enterobacter102 growth co-cultured with C. jejuni for 24 hr.

Enterobacter102 was co-cultured with C. jejuni AR101 for 24 hr. Enterobacter102 growth was
quantified by serially diluting and plating on BHI plates. All graphs depict mean + SEM.
Significant if p <0.05. Results are representative of 3 independent experiments.
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CHAPTER III
Transplantation of specific pathogen free mouse microbiota increases broiler chicken
productivity
3.1

Abstract
Antimicrobial growth promoters have been used to sustain the efficient industrialized

animal production, driving antimicrobial overuse and resistance. It is urgent to develop
antimicrobial free alternatives as growth promoters in poultry production, but few effective
antimicrobial alternatives are currently available. The objective of this study was to investigate the
effect of transplanting microbiota on the bird growth performance. Mouse specific pathogen free
(SPF) stool was cultured on Brain Heart Infusion (BHI) agar under anaerobic or aerobic condition
and collected as SPF-Aerobe and SPF-Anaerobe microbiota. Day-old birds were tagged, weighed,
and randomly assigned to 8 pens with 15 birds/pen. The birds were orally gavaged with PBS (3
pens), 108 CFU/bird SPF-Aerobe (2 pens) or SPF-Anaerobe (3 pens). The feed intake and
individual bird weight were measured at d 0, 14, 21 and 28. The broiler chickens were euthanized
at d 28. Intestinal digesta was collected to measure nutrient and bacteria levels. Notably, SPFAerobe and SPF-Anaerobe significantly increased body weight gain by 18% and 12% during d 0
to d 14, respectively, compared to the negative control. No significant difference of feed intake
was observed among the groups. SPF-Aerobe significantly reduced periodic feed conversion ratio
compared to the negative control by 20% during d 21 to 28. SPF-Aerobe and SPF-Anaerobe
significantly reduced accumulative feed conversion ratio compared to the negative control by 18%
and 14%, respectively, during d 0 to 28. SPF-Anaerobe at d 28 significantly increased the levels
of macro-nutrients of gross energy, protein and fat in the digesta of the small intestine compared
to the negative control. SPF-Anaerobe transplantation at d 28 increased phylum Bacteroidetes but
reduced Firmicutes in the digesta of small intestine and ceca compared to the negative control. In
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conclusion, microbiota was able to improve feed efficiency and early bird body weight gain, and
microbiota reconstitution could be used an effective antibiotic alternative to improve poultry
productivity.
3.2

Introduction
Poultry meat is one of the most consumed animal protein around the world and it accounted

for 50.4% of the animal meat consumption in 2021 in USA [1]. The big market share of poultry
meat has been benefited from the efficiently industrialized poultry production, leading to the
inexpensive and high-quality poultry meat. The efficiency of poultry production has been achieved
because of numerous technology and operation advancements, such as genetic selection, veterinary
medicine, antimicrobial growth promoters (AGP), specialization, and vertical integrated
industrialization [2]. Broiler chickens through commercial quantitative genetic selection from
1957 to 2005 increased growth by more than 400% at d 42, while reducing feed conversion ratio
by 50% [3]. To sustain the fast broiler growth, various husbandry and veterinary innovations have
been developed such as vaccination, AGP, and ecologically controlled housing. To promote
economic efficacy, poultry production has been gradually specialized on individual production
segments including broiler breeder farms, hatchery, broiler grow-out farms, feed mill, processing
plants, and allied industries (e.g. feed additive, vaccine, medicine) [2]. Vertical integration has
further improved the poultry production by owning and controlling multiple stages of the
production as well as the transportation and marketing. The improved poultry production is evident
by reduced wholesale broiler meat price. For example, $ 0.299/lb meat in 1960 [4] was inflationadjusted to $1.47/lb in 2021 [5], a 42% reduction compared to the real price of $0.854/lb in 2021
[4].

76

The animal intestine harbors a complex community of trillions of microbes including
bacteria, archaea, virus, and eukarya. These microbes called microbiota, and their metabolic
activities and products are collectively defined as the microbiome [6]. Modern birds, including
chickens, evolved from theropod dinosaurs around 150 million years ago [7]. Before
industrialization era or in certain countryside, chicken hens have laid and hatched eggs and raised
their chicks, just like their ancestor dinosaurs and wild birds. In the process, the chicks have
acquired microbiota from their parents and living environment. Interestingly, the successful
practice of specialization in modern poultry production [2] has changed many aspects of chicken
life, including microbiota transmission. In the industrialized poultry production, eggs from breeder
hens have been collected, cleaned, and hatched in hatchery and the chicks were raised on fresh or
used bedding or on wire mesh, where the microbiota of the chicks have been acquired from the
living environment and different from their parents’. The microbiota composition of broiler
breeder hen feces are composed of 76% Firmicutes, 13 Actinobacteria, and 4.3% Bacteroidetes
phyla [8]. The small intestinal microbiota of broilers at d 28 is predominant with 97% phylum
Firmicutes [9]. The cecal microbiota of broilers at d 37 has 86% Firmicutes and 13%
Proteobacteria phyla [10]. The separation of breeders and chicks might contribute to the
microbiota composition difference.
Although the disruption of microbiota transmission from parents to their offspring chicks
is apparent, the consequence hasn’t being realized until the recent emergency of antimicrobial
resistance, which is partly caused by AGP usage in poultry production for decades [11]. Increasing
pressure from consumers and government regulations is mounting for taking actions to restrict
AGP, resulting in a variety of challenges in poultry production [12], such as reduced growth
performance and the re-emerging enteric disease of Clostridium perfringens-induced necrotic
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enteritis [13]. Many alternatives have been investigated with various success rates on growth
performance, such as direct feed microbes (probiotics) [14], short chain fatty acids [15], and bile
acids [16, 17]. Recently, we found that specific pathogen free (SPF) mouse microbiota prevents
Campylobacter jejuni chicken colonization [18]. Moreover, microbial metabolite secondary bile
acid deoxycholic acid improves broiler chicken body weight gain [16] and prevents Eimeria
maxima and C. perfringens-induced acute necrotic enteritis [19]. In this study, we hypothesized
that SPF microbiota would improve chicken growth performance. We reconstituted broiler chicken
intestinal microbial community using the SPF mouse microbiota and the growth performance was
measured. We found that SPF Anaerobe microbiota improved chicken feed conversion ratio and
early body weight gain. The results from this study may help developing new antimicrobial free
alternatives for poultry production.
3.3

Materials and methods

3.3.1

Mouse microbiota preparation and transplantation
Animal experiments were performed in accordance with the Animal Research: Reporting

of In Vivo Experiments (https://www.nc3rs.org.uk/arrive-guidelines) and approved by the
Institutional Animal Care and Use Committee of the University of Arkansas (protocol No. 20009
for mice and 20011 for chickens). For this study, SPF BL6 Il10-/- mice were maintained in biosecure settings and fed with ad libitum water and chewing diet cages with Alpha Dry bedding.
Fresh stools were collected from male and female mice between 8 and 10 weeks of age. The stool
samples were cultured on brain heart infusion (BHI, BD Biosciences, NJ) agar plates at 42 °C for
48 hr under aerobic or anaerobic conditions using the GasPak system (BD Biosciences, NJ) and
collected as SPF-Aerobe and SPF-Anaerobe microbiota. The microbiota was added glycerol to
final 30% and stored at -80 °C. Before chicken colonization experiment, the SPF-Aerobe and SPF-
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Anaerobe microbiota were cultured on BHI plate for 48 hr, collected in PBS, and enumerated by
OD600 and plating. OD600 of 1 was estimated at about 108 CFU/ml. Chicks at d 0 were orally
gavaged once with 0.5 ml PBS or 108 CFU/bird SPF-Aerobe, or 108 CFU/bird SPF-Anaerobe.
3.3.2

Management and performance recording of broilers chicken
A total of 120 zero-day-old Cobb 500 broiler chicks (Cobb-Vantress, Siloam Springs, AR)

were randomly allocated into 15 birds per pen. Chicks were transported to an ecologically
controlled housing and were neck-tagged and randomly placed to floor pens. Groups of negative
control (PBS), SPF-Aerobe, and SPF-Anaerobe had 3, 2 and 3 pens per group, respectively. Feed
and water were supplied ad libitum and temperature was maintained according to their age. The
broiler chicks were fed a corn-soybean meal-based starter diet for the first d 0 to 10 and a grower
diet during d 11 to 28. The diets were based on corn and soybean meal and formulated to meet or
exceed published nutrient recommendations as described before [20] and in Table 1. The feed
consumption per pen and body weight per bird were measured at d 0, 14, 21 and 28. The birds
were euthanized at d 14, 21 and 28 for sample collection and pen density reduction. Bird numbers
of negative control, SPF-Aerobe, and SPF-Anaerobe were (62, 48, 22), (28, 20, 20), (45, 33, 28)
during d 0-14, 14-21, and 21-28, respectively. The digesta in ceca and middle small
intestine around diverticulum of birds at d 28 were collected and stored at -80 °C.
3.3.3

Laboratory analysis of feed and digesta macro-nutrients
Frozen small intestine digesta and feed samples were frozen-dried and ground using an

electric grinder to ensure an evenly ground sample. Dry matter, gross energy, ash, nitrogen, and
ether extract (fat) were evaluated in the digesta and feed samples. A bomb calorimeter was used
to determine the gross energy (Parr 6200 bomb calorimeter, Parr Instruments Co., Moline, IL).
The amount of dry matter was calculated based on AOAC [21] method 934.02. Nitrogen was
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measured by combustion method standardized with EDTA (method 990.03 [21]). The fat was
determined using AOAC [21] method 920.39. The nutrient levels of grower feed were 3887
cal/gm, 88%, 3.4%, 9.1 and 3.3 for calories, dry matter, ash, fat and nitrogen.
3.3.4

Estimation of microbiota composition at phylum level
DNA from the eight pooled digesta of small intestine or ceca per group was extracted using

bead beater disruption and phenol: chloroform separation method as described before [18, 22]. The
abundance of five phyla of gut bacteria were determined using SYBR Green PCR Master mix on
a Bio-Rad 384-well Real-Time PCR System (BioRad, Hercules, CA, USA). The qPCR reactions
were performed according to the manufacturer’s recommendation. The primers were used as
described

before

[16],

including

CTCCTACGGGGAGGCAGCAA-3́,
Proteobacteria:

α682F

universal

16S1392R

16S

rRNA:

16S357F

5́-ACGGGCGGTGTGTRC-3́;

5́-CIAGTGTAGAGGTGAAATT-3́,

908αR

CCCCGTCAATTCCTTTGAGTT-3́;

γ-Proteobacteria:

TCGTCAGCTCGTGTYGTGA-3́,

5́-CGTAAGGGCCATGATG-3́;

γ1202R

1080γF

5́α5́5́-

Bacteroidetes:

798cfbF 5́-CRAACAGGATTAGATACCCT-3́,cfb967R 5́- GGTAAGGTTCCTCGCGTAT-3́;
Firmicutes:

928FirmF

ACCATGCACCACCTGTC-3́;

5́-TGAAACTYAAAGGAATTGACG-3́,
Actinobacteria:

Act920F3

1040FirmR

5́-

5́-TACGGCCGCAAGGCTA-3́,

Act1200R 5́-TCRTCCCCACCTTCCTCCG-3́. The relative fold change of each phylum in one
sample were normalized against universal 16S rRNA. The percentage of each phylum was then
calculated as the phylum relative folds divided by total folds of all five phyla.
3.3.5

Bacterial enumeration small intestine digesta
Eight pooled small intestine digesta per groups was weighed at around 0.1 g and suspended

in 500 µl PBS in a 2 ml screw cap tube containing 0.3 g sterile 0.1mm zirconia beads (BioSpec,
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Bartlesville, OK, USA). The samples were briefly homogenized on a Fisher brand Bead Mill 24
Homogenizer (Fisher Scientific, Pittsburg, PA, USA). The samples were then 10x serially diluted
and plated on Brain Heart Infusion (BHI) agar. The plates were incubated on either aerobic or
anaerobic conditions at 42 oC for 48 h using the GasPak system (BD Biosciences, NJ).
3.3.6

Statistical analysis
All values are shown as mean ± standard error of the mean as indicated. Data were analyzed

by One-way ANOVA followed by a Fisher LSD multiple comparison test using Prism 7.0
software. The microbiota counts were transformed with a formula of log10 (CFU + 1). Data were
considered statistically significant if P values were < 0.05.
3.4

Results

3.4.1

The effect of SPF microbiota on periodic and accumulative bodyweight gain
As shown in Table 2 of periodic body weight gain per pen, the SPF-Aerobe and SPF-

Anaerobe microbiota significantly increased periodic body weight gain by 18 % and 12%,
respectively, compared to negative control during d 0 to 14. There was no significance of periodic
body weight gain during d 14 to 21 and d 21 to 28. Similarly, no significant accumulative body
weight gain was observed between groups during d 0 to 21 and d 0 to 28 (Table 3).
Because birds were individually weighed, we also calculated statistics using body weight
gain per bird. The SPF-Aerobe and SPF-Anaerobe microbiota significantly increased periodic
body weight gain d 0 to 14 (0.39 and 0.37 vs. 0.33 kg/bird, respectively, P = 0.0005) and d 14 to
21 (0.35 and 0.40 vs. 0.33 kg/bird, respectively, P = 0.005) (Supplemental Table S1). Consistently,
the SPF-Aerobe and SPF-Anaerobe microbiota significantly increased accumulative body weight
gain d 0 to 21 (0.77 and 0.82 vs. 0.68 kg/bird, respectively, P < 0.0001) and d 0 to 28 (1.35 and
1.42 vs. 1.32 kg/bird, respectively, P = 0.04) (Supplemental Table S2).
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3.4.2

The effect of SPF microbiota on periodic and accumulative feed intake and feed
conversion ratio
Interestingly, there was no significant difference of periodic or accumulative feed intake

between the groups of SPF-Aerobe, SPF-Anaerobe, and negative control, as shown in Tables 4
and 5. During the early days (d 0-14 and 14-21) of SPF-mouse microbiota transplantation, there
was no significant difference of periodic feed convention ratio between the groups (Table 6).
During d 21 to 28, SPF-Aerobe significantly reduced periodic feed conversion ratio by 20%
compared to negative control. Notably, SPF-Aerobe and SPF-Anaerobe significantly reduced
accumulative feed conversion ratio compared to the negative control by 18% and 14%,
respectively, during d 0 to 28 (Table 7).
3.4.3

The effect of microbiota transplant on nutrients of small intestine
We reasoned that the improved growth performance by microbiota transplantation was

resulted from elevated nutrient metabolism. We then measured macro-nutrient levels in the digesta
of the middle of the small intestine. Notably, SPF-Anaerobe significantly increased gross energy
in the digesta by 11% compared to the negative control (Figure 1A). SPF-Anaerobe also
significantly increased digesta fat and protein by 63% and 54%, respectively, compared to the
negative control (Figure 1B).
3.4.4

SPF microbiota colonized in the chicken gut
The improved growth performance and increased macro-nutrient levels indicate a

successful microbiota transplantation. To further reaffirm whether the chicken gut microbiota was
reconstituted with mouse microbiota, we used five phyla-specific primers to analyze changes in
microbiota composition in the small intestine and ceca. In small intestine, SPF-Aerobe and SPFAnaerobe significantly reduced the relative abundance of the phylum Firmicutes compared to the
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negative control (59 and 56 vs. 79%, respectively), while increased the relative abundance of the
phylum Bacteroidetes compared to the negative control (40 and 43 vs. 21%, respectively) (Figure
2A). Consistently, in ceca, SPF-Aerobe and SPF-Anaerobe significantly reduced the relative
abundance of the phylum Firmicutes compared to the negative control (63 and 59 vs. 92%,
respectively,), while increased the relative abundance of the phylum Bacteroidetes compared to
the negative control (37 and 41 vs. 7%, respectively) (Figure 2B). These results indicate that SPFAerobe and SPF-Anaerobe were able to reconstitute chicken gut microbiota.
3.4.5

SPF-Mouse microbiota growth in small intestine digesta of broilers chicken
To further investigate the impact of SPF microbiota transplantation, we also cultured the

bacteria under aerobic or anaerobic condition using the digesta in the bird small intestine. Notably,
SPF-Aerobe and SPF-Anaerobe transplantation significantly increased aerobes by more than one
log compared to the negative control (6.2 and 6.7 vs. 5.3 log10 CFU/g digesta, respectively)
(Figure. 3A). Consistently, SPF-Aerobe and SPF-Anaerobe transplantation increased anaerobes
by around 2 logs compared to the negative control (7.3 and 7.5 vs. 5.7 log10 CFU/g digesta,
respectively) (Figure. 3B). These results illustrate that SPF-Aerobe and SPF-Anaerobe
transplantation have increased bacterial load in chicken small intestine.
3.5

Discussion
Although the industrialization of poultry production and the use of antimicrobial growth

promoters have greatly improved the production efficiency, the associated issues, such as
antimicrobial resistance [23] and animal welfare [24], have been becoming urgent to be addressed.
Among various problems, the disruption of microbiota transmission from parent to offspring has
been largely overlooked. In this study, we reasoned that broiler chicks from commercial hatchery
would be colonized with environmental (e.g. hatchery, transportation vehicles, and grower farms)
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microbiota. The environmental microbiota would not be optimal for chicken growth. To examine
this hypothesis, we reconstituted broiler chicken microbial community by transplanting mouse
SPF microbiota. The choose of mouse microbiota was based on our previous observations that
SPF mice are resistant to foodborne pathogen C. jejuni colonization [18]. We found that SPFAerobe and SPF-Anaerobe increased chicken feed conversion ratio and early body weight gain
compared to negative control. The nutrient levels of gross energy, protein, and lipid in small
intestine of SPF-Anaerobe birds were higher compared to those of negative control birds.
Microbiota composition in small intestine and ceca of SPF-Anaerobe and SPF-Aerobe birds
showed difference to the negative control, indicating the success of the microbiota transplantation.
Altogether, these results suggest that it is possible to transplant microbiota for improving chicken
growth performance.
Accumulating evidence is pointing to the influence of microbiota on body weight gain.
Excessive body weight gain in humans is becoming epidemic issues around the world. Microbiota
has been found to be one of the key factors influencing body weight gain in humans and mice.
Germ-free (GF) C57BL/6 mice colonized with microbiota from the cecum of conventionally raised
mice induces a 60% increase in body fat content and insulin resistance within 14 days despite food
intake reduction [25]. Uncultured or cultured fecal microbiota from adult female twin pairs
discordant for obesity is transmissible to increase total body and fat mass in GF mice which are
fed low-fat chew or high-fat diet [26]. Furthermore, germ-free mice colonized with an ‘obese
microbiota’ results in a significantly higher total body fat increase than ‘lean microbiota’ [27].
Although the donor microbiota in our study was obtained from adult SPF mice with normal body
weight, the transplantation of the mouse microbiota was able to increase recipient chicken feed
conversion ratio and early body weight gain. The results suggest that chicken microbiota naturally
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acquired from our farm environment was not optimal for chicken growth and it was necessary to
establish different microbiota for increasing the bird growth performance. It would be reasonable
to argue that the chicken farms with productivity underperformance would increase productivity
by transplantation of “high performance” microbiota. Furthermore, it would be interesting to see
whether transplanting microbiota from fast growing birds may increase recipient chicken growth
better compared to microbiota from birds with same genetic background but slow growing.
Based on the current knowledge, we reasoned that the increased growth performance by
microbiota transplantation came from enhanced efficiency on nutrient digestibility, absorption,
and metabolism. A core group of eighty-nine carbohydrate active/digestive enzyme families are
present across 85% of the human gut microbiota, while ten of the enzyme families are positively
correlate with higher body mass and encoded in phylum Firmicutes bacteria [28]. Bacteroides
thetaiotaomicron have two hundred sixty glycoside hydrolases in its genome [29]. The order
Lactobacillales and families Lachnospiraceae, and Streptococcaceae are positively associated
with fecal protease activity, whilst the family Ruminococcaceae and an unclassified family
Coriobacteriales are negatively associated with fecal protease activity [30]. Transplantation of
microbiome from obese mice increases the mouse capacity to harvest energy from the diet [27].
Studies using GF and conventionalized mice show that the microbiota colonization increases
absorption of monosaccharides from the gut lumen, resulting in de novo hepatic lipogenesis [25].
In our study, SPF-Anaerobe microbiota transplantation increased the macro-nutrient levels of
energy, protein, and fat in the middle of small intestine compared to the negative control. Those
increased macro-nutrients might be absorbed and utilized by chickens, resulting in improved
growth performance. Interestingly, SPF-Aerobe microbiota transplantation didn’t significantly
increased digesta protein and fat, while the microbiota transplantation increased feed conversion
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ratio. These data suggest that more comprehensive nutrient metabolism analysis in the chicken
microbiota transplantation experiments is needed to understand how much the microbiota impacts
nutrient digestion, absorption and metabolism.
It is a consensus that some of microbiota members are not culturable, but it is inconclusive
whether the culturable microbiota recapitulates the function of the whole microbiota. In medical
practice, a healthy donor’s feces is transplanted without culture to treat a human Clostridium
perfringens infection [31]. The microbiota compositions of the recipients are comparable to those
of the human donor’s, and the C. difficile infection is reduced. Microbiota composition of recipient
piglets is comparable to that of human donors’ in an inter-mammalian fecal microbiota
transplantation [32]. Interestingly, either uncultured or cultured fecal microbiota from human twin
pairs shows different effects on increasing total body and fat mass in GF mice and the recipient
mouse microbiota is consistent with the human donors’ [26]. These results show that it is feasible
to transplant microbiota within class Mammalia. A notable observation from our study is that the
culturable mouse microbiota was able to successfully colonize chickens and to increase chicken
growth performance, suggesting the possibility that culturable microbiota between animals of class
Mammalia (mouse) and class Aves (chickens) in phylum Chordata could transplantable and work
functionally. Interestingly, the difference of intestinal anatomy and body temperature (42 °C in
chickens and 37 °C in mice) did not negatively impact the microbiota transplantation. Chicken
microbiota at the phylum level is mainly consisted of 13 phyla of Firmicutes (70.0%),
Bacteroidetes (12.3%), Proteobacteria (9.3%), and other small proportions of Actinobacteria,
Cyanobacteria, Spirochaetes, Synergisteles, Fusobacteria, Tenericutes, and Verrucomicrobia
[33]. The chicken microbiota composition is often variable from farms to farms. The small
intestinal microbiota of broilers at d 28 is predominant with 97% phylum Firmicutes [9]. The cecal
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microbiota of broilers at d 37 has 86% Firmicutes and 13% Proteobacteria phyla [10]. Consistent
with these findings, we found that phylum Firmicutes was the dominant in birds without a mouse
microbiota transplantation, while microbiota-transplanted birds reduced Firmicutes and increased
Bacteroidetes. Interestingly, the microbiota composition of mice is 54% phyla Firmicutes and 30%
Bacteroidetes [34], which was close to the composition of our transplanted chicken microbiota.
How the microbiota composition is correlated to growth performance remain largely elusive. The
relative abundance of genera Bacteroides and Lactobacillus is higher in the slow-growing breed
birds compared to the fast-growing breed birds, while that of genera Cloacibacillus and
Megasphaera is the opposite [35]. Further research on the relationship between microbiota
members and growth performance will be helpful.
In conclusion, the mouse SPF microbiota was able to colonize chicken small intestine and
ceca and to increase chicken growth performance. The improvement of chicken growth
performance might come from increased nutrient availability. The change of growth might be
related to the reduced bacteria in the phylum Firmicutes and/or increased bacteria in the phylum
Bacteroidetes. Altogether, these findings provide a feasible antimicrobial alternative on increasing
poultry productivity.
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Table 3.1

The composition of the experimental diets fed to broilers between d 0 and 28 posthatched

Ingredient, % as-fed

Starter (0–11 d)

Grower (12–28 d)

Corn
58.17
61.62
Soybean meal (46.8%)
32.9
27.08
a
DDGS
4
6
Soybean oil
1.34
2
Limestone
1.25
1.22
Dicalcium phosphate
0.9
0.74
Salt
0.45
0.42
DL-methionine
0.31
0.26
L-lysine HCl
0.24
0.24
L-threonine
0.09
0.08
b
Trace mineral premix
0.1
0.1
Vitamin premixc
0.1
0.1
d
Sepremix (0.06%)
0.02
0.02
Choline chloride (60%)
0.05
0.04
Santoquin
0.02
0.02
e
Phytase
0.01
0.01
Inert fillerf
0.05
0.05
Calculated composition, % unless noted otherwise
AMEn, kcal/kg
3,015
3,098
CP
22.01
20
Digestible lysine
1.18
1.05
Digestible TSAA
Digestible threonine

0.89
0.77

0.8
0.69

Calcium
Available P

0.9
0.45

0.84
0.42

a

DDGS, distillers dried grains with solubles
Supplied the following per kg of diet: manganese, 100mg; zinc, 100mg; copper, 10.0mg; iodine, 1.0mg; iron,
50mg; magnesium, 27 mg.
c
Supplied the following per kg of diet: vitamin A, 30,863 IU; vitamin D3, 22,045 ICU; vitamin E, 220 IU; vitamin
B12, 0.05mg; menadione, 6.0mg; riboflavin, 26mg; dpantothenic acid, 40mg; thiamine, 6.2mg; niacin, 154mg;
pyridoxine, 11mg; folic acid,
3.5mg; biotin, 0.33 mg.
d
Supplied 0.12mg of selenium per kg of diet.
e
Optiphos®, (Huvepharma Inc., Peachtree City, GA.) provided 250 FTU/kg of diet.
f
Clinacox®, (Huvepharma Inc., Peachtree City, GA), provided 1 mg/kg diclazuril to the diet at the expense of the
inert filler.
AMEn, nitrogen-corrected apparent metabolizable energy.
b
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Table 3.2

Effect of SPF microbiota on periodic body weight (kg) of broilers

Diet
Negative control1

0 to 14
0.33±0.013b

Age (d)
14 to 21
0.34±0.046

SPF-Aerobe1,2

0.39±0.013a

0.35±0.010

0.62±0.041

2

SPF-Anaerobe1,3

0.37±0.006a

0.40±0.060

0.59±0.050

3

21 to 28
0.59±0.035

N (pens)
3

P value
0.03
0.74
0.87
a,b
Means within a column, without common superscript are significantly different (P <0.05).
1
Basal diet (no growth promoter or coccidiostat).
2
Bird gavaged with 108 CFU/bird SPF aerobic microbiota at d 0.
3
Bird gavaged with 108 CFU/bird SPF anaerobic microbiota at d 0.

93

Table 3.3

Effect of SPF microbiota on accumulative body weight (kg) of broilers

Diet
Negative control1

0 to 14
0.33±0.013b

Age (d)
0 to 21
0.68±0.050

SPF-Aerobe1,2

0.39±0.013a

0.77±0.020

1.35±0.021

2

SPF-Anaerobe1,3

0.37±0.006a

0.80±0.067

1.42±0.135

3

0 to 28
1.31±0.059

N (pens)
3

P value
0.03
0.34
0.73
a,b
Means within a column, without common superscript are significantly different (P <0.05).
1
Basal diet (no growth promoter or coccidiostat).
2
Bird gavaged with 108 CFU/bird SPF aerobic microbiota at d 0.
3
Bird gavaged with 108 CFU/bird SPF anaerobic microbiota at d 0.
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Table 3.4

Effect of SPF microbiota on periodic feed intake (kg) of broilers

Diet
Negative control1

0 to 14
0.39±0.023

Age (d)
14 to 21
0.56±0.120

SPF-Aerobe1,2

0.40±0.046

0.50±0.006

0.93±0.059

2

SPF-Anaerobe1,3

0.37±0.004

0.58±0.083

0.99±0.048

3

21 to 28
1.10±0.081

N (pens)
3

P value
0.79
0.86
0.30
a,b
Means within a column, without common superscript are significantly different (P <0.05).
1
Basal diet (no growth promoter or coccidiostat).
2
Bird gavaged with 108 CFU/bird SPF aerobic microbiota at d 0.
3
Bird gavaged with 108 CFU/bird SPF anaerobic microbiota at d 0.
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Table 3.5

Effect of SPF microbiota on accumulative feed intake (kg) of broilers

Diet
Negative control1

0 to 14
0.39±0.023

Age (d)
0 to 21
0.95±0.141

0 to 28
2.04±0.217

N (pens)
3

SPF-Aerobe1,2

0.40±0.046

0.89±0.052

1.83±0.007

2

SPF-Anaerobe1,3

0.37±0.004

0.95±0.086

1.94±0.130

3

P value
0.79
0.94
0.70
a,b
Means within a column, without common superscript are significantly different (P <0.05).
1
Basal diet (no growth promoter or coccidiostat).
2
Bird gavaged with 108 CFU/bird SPF aerobic microbiota at d 0.
3
Bird gavaged with 108 CFU/bird SPF anaerobic microbiota at d 0.
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Table 3.6

Effect of SPF microbiota on periodic feed conversion rates of broilers

Diet
Negative control1

0 to 14
1.18±0.102

Age (d)
14 to 21
1.59±0.154

21 to 28
1.88±0.067a

N (pens)
3

SPF-Aerobe1,2

1.02±0.152

1.41±0.059

1.51±0.004b

2

SPF-Anaerobe1,3

1.00±0.0120

1.47±0.025

1.67±0.063ab

3

P value
0.35
0.53
0.03
a,b
Means within a column, without common superscript are significantly different (P <0.05).
1
Basal diet (no growth promoter or coccidiostat).
2
Bird gavaged with 108 CFU/bird SPF aerobic microbiota at d 0.
3
Bird gavaged with 108 CFU/bird SPF anaerobic microbiota at d 0.
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Table 3.7

Effect of SPF microbiota on accumulative feed conversion rates of broilers

Diet
Negative control1

0 to 14
1.18±0.102

Age (d)
0 to 21
1.36±0.134

SPF-Aerobe1,2

1.02±0.152

1.17±0.120

1.31±0.065b

2

SPF-Anaerobe1,3

1.00±0.0120

1.20±0.012

1.37±0.025b

3

0 to 28
1.60±0.078a

N (pens)
3

P value
0.35
0.40
0.04
a,b
Means within a column, without common superscript are significantly different (P <0.05).
1
Basal diet (no growth promoter or coccidiostat).
2
Bird gavaged with 108 CFU/bird SPF aerobic microbiota at d 0.
3
Bird gavaged with 108 CFU/bird SPF anaerobic microbiota at d 0.
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Figure 3.1

The effect of microbiota transplant on gross energy and nutrients of small intestine.

Frozen small intestine digesta from 8 pooled samples per group was dried and grounded to evaluate
the gross energy (A) and the percentage of macro-nutrient including dry mater, ash, fat and protein
(B). All graphs depict mean ± SEM. Different letters means significant p<0.05.
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Figure 3.2

SPF microbiota modulated the chicken microbiota in small intestine and ceca.

Zero-day-old broiler chickens were colonized with SPF-mouse microbiota. The birds were
euthanized at d 28. Small intestine digesta (A) and cecal digesta (B) from 8 pooled samples per
group was collected and DNA was extracted. Real-time PCR was performed to calculate bacterial
composition at the phylum level. The significance of the phylum Bacteroidetes is represented by
A-B, whereas the significance of the phylum Firmicutes is represented by a-b, p<0.05.
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Figure 3.3

Microbiota enumeration in small intestine digesta.

Small intestine digesta from 8 pooled samples per group was collected from bird at d28 and serially
diluted to enumerate microbiota in both aerobic (A) and anaerobic condition (B). All graphs depict
mean ± SEM. Different letters means significant p<0.05.
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Table S3.1

Effect of SPF microbiota on periodic body weight (kg) of broilers per bird

Diet
Negative control

0 to 14
0.33±0.009b

Age (d)
14 to 21
0.33±0.014b

SPF-Aerobe

0.39±0.011a

0.35±0.007ab

0.62±0.035

SPF-Anaerobe

0.37±0.012a

0.40±0.018a

0.59±0.021

0.0005

0.005

0.61

P value
a,b

21 to 28
0.58±0.018

Means within a column, without common superscript are significantly different (P <0.05).
Basal diet (no growth promoter or coccidiostat). Bird number N = 62, 48, 22 during d 0-14, 1421, and 21-28, respectively.
2
Bird gavaged with 108 CFU/bird SPF- mouse aerobic microbiota, bird number N = 28, 20, 20
during d 0-14, 14-21, and 21-28, respectively.
3
Bird gavaged with 108 CFU/bird SPF- mouse anaerobic microbiota, bird number N = 45, 33, 28
during d 0-14, 14-21, and 21-28, respectively.
1
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Table S3.2

Effect of SPF microbiota on periodic body weight (kg) of broilers per bird

Diet
Negative control

0 to 14
0.33±0.009b

Age (d)
0 to 21
0.68±0.019b

SPF-Aerobe

0.39±0.011a

0.77±0.015a

1.35±0.026ab

SPF-Anaerobe

0.37±0.012a

0.82±0.024a

1.42±0.042a

0.0005

<0.0001

0.04

P value
a,b

0 to 28
1.32±0.041b

Means within a column without common superscript are significantly different (P <0.05).
Basal diet (no growth promoter or coccidiostat). Bird number was the same as in Supplemental
Table S1.
2
Bird gavaged with 108 CFU/bird SPF- mouse aerobic microbiota
3
Bird gavaged with 108 CFU/bird SPF- mouse anaerobic microbiota
1
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CHAPTER IV
4.1

Conclusion
This study evaluated the effect of SPF-mouse microbiota on C. jejuni chicken colonization.

SPF-mouse microbiota was cultured in aerobic and anaerobic conditions and isolated as SPFAerobe and SPF-Anaerobe. The study indicated that both SPF-Aerobe and SPF-Anaerobe mouse
microbiota successfully colonized in chicken ceca and inhibited C. jejuni colonization in chickens.
Reduced bacteria in the phylum Firmicutes and/or increased bacteria in the phylum Bacteroidetes
might explain the decrease in C. jejuni chicken colonization. Consistently, SPF-mouse microbiota
inhibited C. jejuni growth in vitro. Moreover, we were able to isolate bacterium from the SPFanaerobe microbiota and identified as Enterobacter102. Enterobacter102 was able to inhibit C.
jejuni growth in vitro and chicken colonization. Moreover, we studied the effect of SPF-mouse
microbiota on broilers chicken growth performance. The study showed that SPF-Aerobe and SPFAnaerobe significantly increased body weight growth by 18% and 12%, respectively, during day
0 to day 14. There were no significant differences in feed intake between the groups. During day
21 to 28, SPF-Aerobe substantially decreased periodic feed conversion ratio by 20% compared to
the negative control. SPF-Aerobe and SPF-Anaerobe microbiota reduced accumulative feed
conversion ratio compared to negative control by 18% and 14% respectively, during d 0-28. In
addition, SPF microbiota increased the amounts of gross energy and macro-nutrients including,
protein and fat in small intestine digesta compared to the negative control. Lastly, SPF-mouse
microbiota transplantation increased phylum Bacteroidetes and reduced Firmicutes in small
intestine and cecal digesta.
Following those discoveries, several future directions could be explored. It will be
important to identify specific bacterial members in the SPF microbiota using 16S rDNA
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sequencing and individual bacterial culturing. The identified bacteria could be individually and
combinedly assessed for their capacity to reduce C. jejuni growth in vitro and colonization in
chickens. The bacteria could also be individually and combinedly examined for improve chicken
productivity. Secondly, the microbial metabolites produced by the microbiota could be the
contributing factors and be identified using targeted and untargeted metabolomics. The discovery
of the metabolites could be coupled with the identification of specific microbiota members. The
identified microbiota metabolites could be used to prevent C. jejuni infections in chickens and
humans. Thirdly, host immune responses modulated by the microbiota could be contributing
factors. Although no host immune responses have been investigated in these projects, it was
possible that the interaction of host immune response, microbiota, and metabolites occurred. The
anti-inflammatory response by microbiota is implicated in gnotobiotic experiments. Altogether,
these findings and future research may help the development of effective strategies to reduce C.
jejuni chicken contamination and campylobacteriosis in humans and increase poultry productivity.
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